Digital Health Technologies

SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

Volta Labs develops automated sample preparation solutions for genomic and sequencing workflows. The company's platform enables walk-away sample prep for a wide variety of sample types and is compatible across multiple NGS and long-read sequencing technologies. Their system focuses on operational efficiency, robust performance, and high-quality output for DNA/RNA extraction, library preparation, and target enrichment.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

MANTECH is a premier provider of advanced technology solutions and services for national security, defense, intelligence, and federal civilian markets. With over 50 years of experience, MANTECH delivers mission-driven innovation across all domains—land, sea, air, space, and cyberspace—supporting complex operations with agility, precision, and speed. The company is recognized for its deep expertise in cybersecurity, data and AI, digital transformation, and intelligent engineering, empowering clients to achieve their goals and secure the future. MANTECH's mission is to deliver technology-driven innovation and next-generation capabilities, setting the standard for excellence and reliability in supporting critical government missions. The company is also known for its strong leadership team, culture of innovation, and commitment to professional growth and diversity.

Nuclera develops automated benchtop platforms and integrated systems for rapid protein expression, optimization, and purification, utilizing cell-free synthesis, digital microfluidics, and software-driven workflows. Their technology enables miniaturized and scalable protein prototyping—including challenging targets such as membrane proteins—directly at the lab bench. Nuclera serves academic and industrial researchers, focusing on reducing turnaround time for functional protein access and streamlining screening and production. The company has secured significant funding to enable broad commercialization, expanded their leadership team to support scale-up, and continues to drive advancements in drug discovery, proteomics, and experimental automation.

Alithia Life Sciences is an Australian-owned, boutique, full-service Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, device companies, and institutional research groups with their projects in Australia and beyond. With over 25 years of operational expertise across a wide range of therapeutic areas, Alithia offers personalized project management from Phase I to Phase III, aiming to deliver efficient project outcomes, add value to client programs, and ultimately improve human health and wellbeing.

LumenAstra, Inc. is at the forefront of developing innovative, wearable, non-invasive sensors for accurately measuring internal body temperatures. Originating from a need identified by DARPA to protect troops from heat stress, the company collaborates with the University of Colorado's Radio Frequency Lab to commercialize a patented technology. This technology, initially used for astronomical measurements, is now being adapted to monitor critical health parameters such as brain and tumor temperatures, promising to revolutionize medical monitoring and treatment.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company focuses on purpose-driven innovation to empower healthcare professionals and enhance patient outcomes across various medical fields.

The National Foundation for Integrative Medicine (NFIM) is dedicated to transforming healthcare through innovative solutions and technologies. With a mission to shorten the technology transition cycle and improve health outcomes, NFIM focuses on patient care innovation and supports various populations, including veterans and clinicians, in accessing safer and more effective healthcare options.

Physical Sciences Inc. (PSI) is an employee-owned company dedicated to inventing, demonstrating, and translating technologies that address critical national needs in defense, security, healthcare, and environmental stewardship. With over 50 years of experience, PSI combines extensive research and development capabilities with a commitment to innovation and customer focus.

Qidni Labs is a NATO DIANA company recognized by Fast Company as a 2025 World Changing Idea. The company has developed a portable, nearly waterless hemodialysis system that will make treatment accessible for over 10 million patients every year.

Pradazka, by Integrative Mechanical Medical Devices LLC, is dedicated to revolutionizing in-patient care through innovative wireless and continuous patient monitoring technology. Their mission is to empower patients and healthcare professionals with advanced, AI-driven wearable devices that enable continuous tracking of vital signs, enhancing patient mobility, safety, and care outcomes. The company is committed to driving progress in digital health and seeks partnerships and funding to further its impact on healthcare.

VirTech Bio is an early-stage biotechnology company based in Natick, Massachusetts, focused on developing a human-derived hemoglobin-based oxygen carrier (HBOC) for use as a temporary blood substitute in trauma and transplantation. The company leverages expertise in hemoglobin polymerization to address critical needs in emergency medicine and organ preservation, with a pipeline also targeting veterinary and research applications. Process innovations allow scalable and contract-based manufacturing, supported by significant non-dilutive funding from the US Department of Defense and private investment.

Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.

Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.

STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.

CRI Genetics, part of the Cellular Research Institute, aims to unlock complex genetic information and present it in an engaging and useful manner. Their mission is to enhance human life and advance the understanding of the human genome through consumer genetic reports and active participation in scientific research. They believe genetic analysis is the future of medicine and are committed to solving complex medical problems. The company ensures the privacy and security of customer data, offering an 8-week efficiency guarantee for delivering genetic reports.

The American Burn Association (ABA) is a multidisciplinary organization dedicated to improving the lives of those affected by burn injury. With over 3,000 members worldwide, ABA focuses on promoting and supporting burn-related care, prevention, education, and research. The association brings together professionals from various disciplines to advance quality care, advocate for prevention, provide educational resources, and foster research in the field of burn injuries. ABA is also recognized for its leadership in advocacy, professional development, and the establishment of best practices and guidelines for burn care. The ABA regularly hosts conferences, develops clinical guidelines, and partners with organizations to raise awareness and improve outcomes for burn survivors.

Pulsara is a purpose-driven healthcare technology company focused on improving the lives of patients and caregivers through innovative, real-time communication and collaboration. Their telehealth platform connects clinicians, EMS, hospitals, and emergency management teams on a single patient channel, enabling dynamic, scalable, and secure care coordination for any illness or injury. Pulsara's evidence-based solutions are designed to reduce treatment times, lower costs, and enhance experiences for both patients and providers. The company is recognized for its customer-first values, award-winning support, and commitment to privacy, security, and interoperability.

MK Strategy Group is a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and a leading government contractor specializing in innovative healthcare solutions for military, government, and commercial sectors. With over two decades of experience, the company excels in medical procurement and facility development. MK Strategy Group bridges the gap between medical technology providers and government agencies, offering tailored, turnkey solutions that accelerate success in the government market. Their approach combines military precision, deep industry expertise, and a commitment to quality, innovation, and financial stability—enabling them to manage large-scale, complex projects with efficiency and reliability.

The Precision Vaccines Program (PVP), based in the Department of Pediatrics at Boston Children’s Hospital, is an academic research initiative dedicated to discovering and developing next-generation vaccines tailored to vulnerable populations. PVP conducts both basic and translational research to create novel vaccines and therapeutics for diseases that disproportionately affect infants, older adults, and immunocompromised individuals. The program brings together experts in vaccinology, clinical trials, immunology, molecular biology, data management, biostatistics, bioinformatics, and systems biology, fostering international collaboration among academia, government, and industry to advance precision medicine in vaccinology.

Vocxi Health is a diagnostic start-up focused on early disease detection through its innovative MyBreathPrint® system. This noninvasive technology allows for immediate health assessments by analyzing volatile organic compounds (VOCs) in a patient's breath, aiming to revolutionize patient care and improve health outcomes.

Seek Labs is a biotechnology company headquartered in Salt Lake City, Utah, dedicated to advancing scientific discovery and delivering universal healthcare solutions. The company specializes in next-generation point-of-care molecular diagnostics and programmable CRISPR-based therapeutics, aiming to bridge the gap between disease outbreak and intervention. Powered by its proprietary AI discovery engine, BioSeeker™, Seek Labs is building a modular, full-stack system that enables rapid response to emerging pathogens, scalable precision treatments, and accessible diagnostics. The company is committed to global health innovation, sustainability, and community engagement, and is a proud member of Utah's BioHive life sciences ecosystem. Seek Labs' mission is to empower individuals with healthcare solutions tailored to their specific needs, revolutionizing the detection and treatment of diseases for both human and animal health.

BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.

Sonogen Medical Inc. is dedicated to researching, developing, and commercializing next-generation ultrasonic bone fracture healing technology. The company combines expertise in fluid mechanics, biophysics, sonar, and medical ultrasound to create safe and effective devices for bone healing.

Ethos Solutions specializes in rapid problem solving in dynamic environments through the Ethos IDEALs (Identification, Define, Engagement, Alignment, and Leveraging). Ethos leverages module working groups (or cells) consisting of Subject Matter Expert (SMEs) clinicians, training cadre, warriors, academics, and researchers able to rapidly identify and solve problem sets that require a grounded approach forged in austere and dynamic environments.

Xtory is a Harvard spin-off that combines AI and 3D technology to revolutionize healthcare and education. The company aims to provide trustworthy medical information and decision-making tools to improve patient outcomes and streamline clinical workflows. With a focus on innovation and scientific rigor, Xtory is dedicated to reshaping healthcare through AI-driven solutions.

cosinuss° is a medical technology company based in Munich, Germany, that is pioneering an ultralight monitoring solution in Europe for situations and use cases where the currently available monitoring solutions fail. The company specializes in in-ear biosensor technology connected to mobile devices for local application, and/or additional cloud-based analytics, supporting real-time local and remote patient monitoring for medical care in challenging operations, in remote environments, clinical trials, remote patient monitoring, and telemedicine. The solution is currently only available for sale in Europe.

Vindhya Data Science is a women-owned small business headquartered in North Carolina, USA, with a presence in RTP and Boston. We specialize in bioinformatics, genomics, artificial intelligence, and data engineering, cheminformatics, evidence-based medicine, epidemiology and related disciplines. Vindhya partners with federal government agencies, leading academic medical centers, and pharma/biotech organizations to transform large datasets into informed decisions using advanced data science technologies. With over 100 years of combined experience, 150+ publications, and 73+ successful projects, Vindhya is committed to delivering impactful solutions in the life sciences sector.

CranioSense, Inc. is a clinical stage company focused on revolutionizing the measurement of intracranial pressure (ICP) with their innovative IPASS technology. This non-invasive solution aims to provide rapid and safe ICP assessments, addressing the critical need for better management of traumatic brain injury (TBI) and other conditions associated with elevated cranial pressure. By eliminating the need for invasive procedures, CranioSense is poised to significantly improve patient outcomes and healthcare practices.

HELM Innovations is a service-disabled veteran-owned small business specializing in the integration of science, technology, and programmatic and strategic solutions, primarily for U.S. federal government clients. With over 30 years of experience in national security, systems engineering, and interagency collaboration, the company provides expertise in areas such as complex systems acquisition, R&D, environmental lab testing, crisis response, and leadership development. HELM Innovations is noted for applying advanced business models, fostering cross-disciplinary teamwork, and supporting rapid, effective decision-making in complex environments.

Auspex Medix focuses on developing AI-driven medical technologies aimed at improving patient outcomes and supporting healthcare professionals. Their solutions are designed to be secure, interoperable, and adaptable across various medical specialties, emphasizing evidence-based decision support and human-in-the-loop workflows.

From Rapid Innovation to Breakthrough Impact, Bessel Helps Startups and Scaling Teams Move Faster, Smarter, and Together with Fewer Missteps. Experience Bessel Rapid Innovation: We embed with your team to rescue stalled projects or fill critical gaps. From R&D to Quality Systems to Regulatory Affairs, we drive rapid progress to reduce your burn rate and improve profitability. We help your team deliver measurable results: reduced COGS, decreased complaints, improved performance. Our Powered by Bessel™ Accelerator is an Intensive, fixed-duration programs to refine your technology strategy, align teams, and prepare for fundraising—perfect for startups seeking clarity and velocity. Save months in development, find your sweet spot with investors, build and support your team. The Bessel Origin™ workforce development program, born in the classroom, trains emerging medtech teams in design thinking and agile teamwork, fueling innovation. Boost team performance and identify, develop, and retain your emerging leaders.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

JDSAT is a decision science company that fuses human insight with algorithmic precision to help organizations make faster, better-informed decisions, when the stakes are high, and the margin for error is low. We work across defense, interagency, and health sectors to build decision ecosystems that thrive in uncertainty. Whether you're leading transformation inside government or solving tough problems as a prime, JDSAT is your edge in complexity.

Lumia Health is dedicated to empowering individuals with chronic blood flow disorders to better self-manage their symptoms through breakthrough wearable technology. Their mission is to make previously unmeasurable symptoms—such as dizziness, brain fog, and fainting—trackable and understandable, especially for those with conditions like POTS, Dysautonomia, Orthostatic Hypotension, Long COVID, and ME/CFS. By combining advanced ear-worn sensors with a companion app, Lumia Health provides real-time insights into blood flow to the head, helping users identify what helps or hinders their well-being. The company collaborates with world-class researchers and medical institutions to ensure the highest standards in research, development, and patient care.

Booz Allen Hamilton is a leading management and technology consulting firm with over 110 years of experience. The company is dedicated to empowering people to change the world through innovative solutions in various sectors including cybersecurity, artificial intelligence, engineering, and defense. Booz Allen partners with government and commercial clients to tackle their most complex challenges, leveraging a culture of innovation and a commitment to excellence. The firm operates with core values of integrity, courage, service, ingenuity, and a commitment to diversity and inclusion.

Harmac is a global contract design and manufacturing organization specializing in single-use medical devices. With over four decades of experience, Harmac provides comprehensive services including product design and development, advanced manufacturing, automation, value engineering, quality assurance, and packaging and sterilization. The company is known for its operational excellence, regulatory compliance, and commitment to sustainability and community engagement. Harmac operates facilities across the United States, Ireland, and Mexico, supporting customers worldwide and across a range of clinical applications. ISO 13485 Certified and FDA Registered.

VelocityTX, formerly the Texas Research & Technology Foundation, is a nonprofit organization dedicated to advancing San Antonio’s life sciences and bioscience industry to drive sustainable economic and community growth. By leveraging the region’s strengths in research, development, and commercialization, VelocityTX fosters innovation through place-based industry clustering, startup support programs, and workforce development. The organization is developing a 70-acre innovation district on San Antonio’s East Side, anchored by the redeveloped Merchants Ice Complex and the future G.J. Sutton property, to serve as a hub for biosciences, technology, and military medical research. VelocityTX connects academia, industry, and military partners, supporting early-stage companies, facilitating collaboration, and positioning San Antonio as a national leader in medical innovation and economic impact. The organization has a rich history dating back to 1984 and has recently unified its brand under the VelocityTX name to reflect its expanded mission and impact.

PinMed, Inc., is a National Innovation Award-winning bioinformatics/medical-device company that develops high-fidelity cardiovascular monitoring systems, personalized (adaptive) software, and integrated systems and custom solutions for tracking cardiovascular data in the most challenging environments (e.g., intensive activity, extreme electromagnetic interference, and interventional cardiovascular procedures) and identifying subtle but clinically important indicators of cardiovascular events. PinMed’s award-winning solutions include versatile, multisensor, high-fidelity monitoring systems for various hospital and ambulatory settings. The company has extensive experience in electronic and mechanical engineering, development of software and firmware for various processors, computational modeling, and cardiovascular physiology. PinMed’s flagship mobile platform, PELEX, provides unparalleled versatility in physiological monitoring and has been cleared by the FDA for diagnostic 12-lead ECG testing and various types of ambulatory monitoring.

Cooper University Health Care is a regional academic health system recognized for comprehensive clinical services, advanced multidisciplinary care, specialized surgery, and robust research in South Jersey. It provides integrated healthcare across general and specialty domains, including cancer, neurosciences, cardiology, trauma, genetics, addiction medicine, and complex surgical procedures, supported by leading technologies and a network of modern facilities.

DLH delivers improved health and national security readiness solutions for federal programs through science research and development, systems engineering and integration, and digital transformation. With over 3,200 employees, DLH is committed to solving complex problems faced by civilian and military customers, leveraging advanced technologies and methodologies to enhance health outcomes and operational readiness.

Sunflower Therapeutics is a women-owned and led biotechnology public benefit corporation founded in 2018, dedicated to democratizing access to protein manufacturing worldwide. The company develops next-generation, automated, and fully-integrated protein manufacturing solutions that simplify the process from discovery to full-scale biomanufacturing. Their mission is to make high-quality, cost-effective therapeutics, vaccines, and protein-based products accessible globally, especially in low- and middle-income countries, by leveraging innovative technologies, sustainable practices, and intuitive equipment. Sunflower’s vision is to transform the global health landscape by enabling more medicines and protein products to reach patients and consumers everywhere. Their core technologies include efficient microbial hosts, data-driven process development, and modular manufacturing facilities, supporting agile, rapid, and cost-effective production cycles for a wide range of protein-based products.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

IntelliDyne, LLC is a consulting firm that enhances business performance and mission outcomes through innovative technology solutions. The company specializes in managing public sector programs to deliver higher operational efficiency and measurable value to clients. IntelliDyne offers expertise in Advanced Analytics, Information Assurance/Cyber Security, Cloud Computing, Application Development and Mobile Computing, and Enterprise Infrastructure Management. With a commitment to veterans and a people-first culture, IntelliDyne has been recognized as a top workplace and a leader in supporting military families.

Military Operational Medicine funded for PTSD, Adjustment Disorder and Pain and Sleep (over $5m). 3 trials in progress. Sana Health is an FDA Breakthrough Designated Device, currently in front of the FDA for Neuropathic Pain as a de novo - expecting to be on market Q4 2025. Sana is a wearable audiovisual neuromodulation device, that provides anxiety and pain relief, and sleep on demand. $25m raised to date, and in the middle of a Series A extension SAFE note round.

TIMSER S.A.P.I. de C.V. is a biomedical company in Mexico developing accessible and non-invasive blood-based screening solutions for early detection of cervical cancer and its precursor lesions. The company leverages more than a decade of research to advance clinically validated molecular diagnostics using protein biomarkers identified through proteomics and molecular biology approaches. These technologies address barriers to traditional screening and are backed by extensive national and international patent coverage and clinical trial validation involving hundreds of participants.

Entropia Labs focuses on advancing functional medicine and wellness therapeutics through AI-driven molecular design and delivery technologies. The company aims to close the gap between promising treatments and rigorous scientific validation, with an emphasis on health-span extension.

Omedus LLC develops technologies to improve real-time triage and emergency response in healthcare and crisis environments. Their solutions focus on automated, wireless patient assessment systems that provide dynamic prioritization for first responders, medics, and emergency teams. The company collaborates with defense, technology, and academic partners to drive innovation in data-driven emergency care.

Tietronix Software, Inc. is a minority-owned small business founded in 1999, located in Houston, Texas, near NASA Johnson Space Center. The company specializes in providing innovative software solutions and services across various sectors including medical, aerospace, and renewable energy. Tietronix is committed to high quality, reliability, and customer satisfaction, leveraging a diverse workforce and a strong project management team to deliver complex, mission-critical systems.

NEXT Labs is pioneering the automation and accessibility of next-generation sequencing (NGS) by developing affordable, portable solutions for sample and library preparation. Their mission is to enable sequencing anywhere, by anyone, moving NGS from specialized labs to point-of-need applications. By automating complex sample processing steps, NEXT Labs aims to democratize genomics research and diagnostics, making advanced testing faster, more accessible, and cost-effective for a wide range of applications including infectious disease detection, cancer, and neurodegenerative disease diagnostics.

Sibel Health is dedicated to delivering Better Health Data for All®, utilizing advanced wireless monitoring technologies to improve healthcare outcomes globally. Founded by leading engineers and scientists, the company focuses on transforming clinical trials and care through innovative wearable sensors and data integration.

Senseye is pioneering a breakthrough diagnostic platform for mental health, focusing initially on PTSD. The company aims to empower clinicians with fast, accurate tools to personalize care by establishing clear baselines and tracking outcomes over time. Senseye's innovative approach leverages brain-based diagnostics and computer vision technology to transform the diagnostic process for PTSD, anxiety, depression, and addiction into an objective process. Their platform operates on everyday smartphones, making it accessible and efficient, without the need for specialized equipment.

Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.

Intellisense Systems, Inc. develops and manufactures advanced technologies that modernize armed forces and support commercial and government operations through innovative defense electronics, avionics displays, and environmental monitoring systems. The company specializes in replacing obsolete electronic systems, providing rugged, modular, and autonomous solutions for weather monitoring, avionics displays, power management, and more. With a strong focus on quality, innovation, and mission-readiness, Intellisense serves military, commercial, and government clients, delivering products that enhance operational efficiency, safety, and situational awareness in the most demanding environments. Their solutions are designed for compatibility with legacy systems and open architectures for future upgrades, ensuring long-term value and reduced lifecycle costs. Intellisense's Micro Weather Station (MWS) series is deployed in over 60 countries and on all 7 continents, and the company is recognized for its rapid innovation, including the development of the world's smallest lidar ceilometer and advanced power distribution solutions.

Altec is dedicated to advancing human potential by developing innovative human sensing technologies that enhance health science, operational security, and human performance. Founded in 1997 by Carlo De Luca, the company focuses on translating cutting-edge concepts into practical solutions that shape our understanding of human physiology. Altec's mission is to reimagine human potential through discovery, innovation, and collaboration, making significant strides in healthcare, security, and performance enhancement.

Exponent is a multidisciplinary science and engineering consulting firm serving sectors including healthcare, energy, manufacturing, and consumer products. From medical devices, pharmaceuticals, and supplements to digital health and wearables, we deliver rigorous science that quantifies impacts on human health. Exponent helps you push the envelope on the development, deployment, safety, and effectiveness of cutting-edge drugs, devices, and diagnostics — concomitantly balancing benefits and risks. Count on our multidisciplinary, data-driven, evidence-based assessments to give you clarity on your most complex product needs and challenges. With lives on the line, innovations that support healthcare demand the highest levels of scientific rigor. Whether you’re developing a novel drug, a sturdier stent, or a faster flu test, you need clear answers to complex questions, quickly. Exponent supports our life sciences clients across the total product lifecycle by solving critical design, regulatory, safety, and market access challenges. We can collaborate with you throughout your journey, helping you navigate risks and opportunities — and optimize outcomes — with science-based strategies and specialized expertise.

Stream Biomedical is a clinical-stage biotechnology company developing first-in-class biologic therapies to restore neurological function by activating the brain’s natural repair mechanisms. Founded in 2016, the company is advancing a protein therapeutic focusing on treating brain injuries and neurodegenerative diseases—including stroke, traumatic brain injury, and Alzheimer’s disease—by supporting neurovascular repair and modulating inflammation. Stream Biomedical’s approach is underpinned by rigorous preclinical and translational research, with the goal of changing outcomes for patients affected by severe neurological conditions.

Kaléo is a global leader in drug-delivery device technology and auto-injector innovation, providing millions of patients with security and peace of mind. Our patented Aerio™ platform, with unmatched capabilities and human factors engineering, powers our portfolio of auto-injector products, as well as products under development for third parties.

Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.

The University of Cincinnati Office of Research is a premier R1 urban research institution dedicated to advancing transformative knowledge and disruptive discoveries that address real-world challenges. Guided by its Research2030 strategic plan, the Office fosters interdisciplinary collaboration, supports innovative research initiatives, and connects industry, government, and community partners with UC's thought leaders. The Office accelerates economic growth and societal impact by investing in key research strengths such as analytics, cyber, robotics, sensors, skin science, adolescence, cancer, digital humanities, infectious diseases, medical devices, neuroscience, smart cities, sustainability, urban futures, and water. With a strong commitment to transparency, compliance, and research security, the Office provides comprehensive support for faculty, students, and staff throughout the research lifecycle, ensuring excellence and integrity in all scholarly activities. Specialized programs and support offices include biosafety, animal care, research integrity, cybersecurity, human research protection, defense research initiatives, government cost compliance, and radiation safety, all designed to uphold the highest standards of ethical, safe, and innovative research. The Office also keeps the community informed and engaged through its monthly 'Findings' newsletter, highlighting impactful research, partnerships, and opportunities.

Thornhill Medical specializes in advanced medical technologies for critical care, anesthesia, respiratory therapy, and vascular diagnostics. Their core offerings address clinical needs in austere, emergency, battlefield, and transport environments, enabling mobile and integrated life support, portable anesthesia, and precise non-invasive control and measurement of blood gases. With significant expertise in both product engineering and translational clinical research, the company supports deployments worldwide, collaborates with military and civilian partners, and contributes to innovation in healthcare delivery and device interoperability.

Simbex is a leading partner in medical device and consumer health product design and development, recognized for transforming complex ideas into commercially successful solutions. With a multidisciplinary team, Simbex excels in engineering, product design, software, data analytics, and commercialization strategy, supporting innovators from concept to market. Their mission is to deliver impactful medical devices and consumer health products that improve health outcomes and quality of life. Simbex is known for its holistic approach, deep regulatory expertise, and commitment to innovation and excellence in the health technology sector. The company is also active in thought leadership, regularly publishing regulatory and reimbursement updates, and hosting educational webinars for the MedTech community. Simbex maintains a robust Quality Management System compliant with ISO 13485 and FDA 21 CFR 820, ensuring high standards in product development. The company is also committed to supporting diversity in MedTech, including initiatives for women in the sector. Simbex's leadership and advisory team bring decades of experience in biomedical engineering, commercialization, regulatory affairs, and technology innovation, further strengthening its position as a trusted partner in the MedTech ecosystem.

The Nanovaccine Institute, established at Iowa State University in 2017, is a national transdisciplinary research consortium focused on advancing nano-based technologies to treat and prevent diseases. The institute aims to revolutionize public health outcomes through the design and promotion of nano-based vaccines and therapeutics.

Aptima, Inc. is a leader in optimizing and improving human performance in mission-critical, technology-intensive environments. Since 1995, Aptima has combined social science principles with advanced computational methods to deliver innovative, human-centered engineering solutions for defense, intelligence, aviation, law enforcement, and healthcare sectors. The company is recognized for its multidisciplinary approach, integrating expertise from engineering, data science, psychology, and cognitive science to address complex challenges. Aptima is committed to advancing research and development in artificial intelligence, machine learning, data analytics, and simulation, with a strong focus on enhancing human-machine teaming, learning, and readiness. Their mission is to ensure synergy between humans, technology, and organizations, accelerating learning and productivity in the age of AI. Aptima's culture is rooted in innovation, impact, and empathy, fostering an inclusive and supportive environment for its diverse team of experts.

Ejenta is dedicated to enhancing healthcare through intelligent agents that leverage AI technology, originally developed for NASA. Their mission is to provide connected care solutions that improve health outcomes by utilizing data from sensors and IoT devices to monitor and support users in real-time.

Makani Science, Inc. is dedicated to transforming respiratory care by making respiratory monitoring more accessible, accurate, and comfortable. Originating from over a decade of research at the University of California, Irvine, the company was founded to address the critical need for reliable breathing monitoring in clinical and home settings. Their mission is to improve patient health by providing healthcare professionals and patients with better data, enabling earlier detection of respiratory issues, and enhancing quality of life through advanced biofeedback and wellness applications.

TRI Medical, Inc. develops and supplies educational simulation models and training services to enhance the diagnostic and manual skills of healthcare professional students and new graduates. The company focuses on providing real-time, psychomotor feedback tools for medical education programs and healthcare organizations, aiming to improve confidence, self-efficacy, and diagnostic accuracy prior to clinical practice.

IVIR Inc. is a leader in research and development in education, medical education, and modeling and simulation. Established in 2008, IVIR’s team of professionals represents decades of comprehensive experience in cutting-edge research and development of information visualization technologies for the US Military and civilian markets. The company aims to achieve measurable results that make a lasting impact and ultimately save lives.

Phelix Medical is a precision health company dedicated to advancing pharmacogenomics (PGx) as a tool for health equity, safer prescribing, and personalized care. We specialize in delivering inclusive PGx testing, real-time clinical decision support, and secure data integration for providers, payers, and patients—particularly in underserved and high-risk populations. Through strategic partnerships with CLIA-certified labs, EHR integrators, and public health educators, Phelix Medical supports scalable PGx programs across federal systems, community clinics, and telehealth networks. Whether improving medication safety for military health readiness or enabling precision prescribing in minority communities, our solutions are built to inform, empower, and deliver outcomes where they matter most.

Prolucid Technologies Inc. specializes in custom software development for highly regulated industries, including medical and nuclear sectors. With over 17 years of experience and more than 1200 projects completed, Prolucid delivers robust, secure, and compliant software solutions. The company is ISO 13485 certified for medical software and adheres to CSA N299.1 and ISO 9001 standards for nuclear applications. Prolucid offers end-to-end services from project definition and planning to design, development, verification, and ongoing support, leveraging advanced technologies such as AI, ML, computer vision, and cloud infrastructure.

The UVM An-Cockrell Lab Center for Biomedical Digital Twins is a multidisciplinary research group leveraging advanced computational methods, including machine learning, agent-based modeling, and high-performance computing, to study complex biomedical and physiological phenomena. Their mission is to bridge the gap between basic science and clinical interventions by developing digital twins and computational models that inform precision medicine, therapeutic discovery, and translational research. The lab's work spans detailed organ and disease modeling, AI-driven clinical applications, and collaborative projects such as DARPA-funded initiatives, aiming to revolutionize healthcare through technology and simulation.

Martin, Blanck & Associates, LLC (MBA) is a healthcare consulting firm based in Alexandria, Virginia, founded in 1998 by Dr. Edward Martin and Mr. Alfred Giambone. The firm specializes in providing critical assistance to private sector clients, nonprofits, associations, and universities focused on federal healthcare delivery systems, public health programs, and government contracting. With over two dozen senior executive partners and more than 500 years of combined healthcare experience, MBA offers expertise in healthcare policy, program development, executive management, strategic planning, informatics, medical countermeasures, public health strategies, and emerging infectious diseases. The firm is committed to professionalism, ethical service, and delivering results for clients in both the public and private sectors.

Profusa, Inc. is a pioneering digital health company based in the San Francisco Bay Area, dedicated to making the body’s chemistry easily accessible to improve health and wellness. Profusa develops tissue-integrating biosensors for continuous, real-time monitoring of body chemistries, empowering individuals and clinicians with actionable, medical-grade data to transform personal health management and disease prevention. Their unique bioengineering approach overcomes the foreign body response, enabling long-term, in-body monitoring through tiny, flexible biosensors that become one with the body. Profusa’s technology platform supports both consumer and medical applications, with a vision to revolutionize personalized medicine and digital health. The company is supported by significant grant funding from agencies such as DARPA and NIH, and collaborates with leading academic, hospital, and industry partners worldwide.

Govmates is a free business development tool designed to support small government contractors. It offers a unique matchmaking service that connects small businesses with large government contractors, facilitating targeted networking and business development. Govmates aims to provide visibility and opportunities for small businesses to team up with larger partners, enhancing their access to government contracts. The platform is committed to fostering collaboration and innovation within the government contracting community.

Policy Wisdom, LLC is a global public health policy consulting firm founded in 2010, dedicated to delivering evidence-based solutions that positively impact public health worldwide. With a mission to be a benchmark of excellence in health policy, Policy Wisdom partners with governments, NGOs, pharmaceutical companies, and advocacy groups in over 150 countries. The company leverages a 100% virtual business model and a diverse, expert team to provide innovative methodologies and client-centered strategies. Their work spans policy strategy development, capacity building, evidence generation, and the creation of educational resources, all aimed at measurable improvements in health systems and equitable health outcomes. Policy Wisdom is recognized for its leadership in decolonizing global health, advancing precision medicine, and shaping policies that address both emerging and persistent public health challenges across the globe.

Via Product Development (Via PD) helps turn ambitious visions into successful products by providing expert guidance throughout the entire product development lifecycle. We specialize in electronics design and development, helping clients navigate from initial concept through to manufacturing. With a focus on clear communication, strategic planning, and technical excellence, we help teams reduce risk and accelerate timelines. We leverage deep industry expertise and strong partnerships to ensure optimal product-market fit and successful commercialization, particularly in highly regulated and technically complex sectors.

Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.

Accenture is a global professional services company with extensive capabilities in strategy and consulting, digital transformation, technology, and operations. The company aims to drive innovation and efficiency across various industries, helping clients navigate complex challenges and seize opportunities in a rapidly changing environment. Accenture is committed to creating positive change around the world and ensuring responsible business leadership for its people, clients, and communities. The company emphasizes continuous learning, responsible AI practices, and a culture of belonging and diversity.

Cogwear is a US-based neurotechnology company specializing in wearable EEG devices that deliver clinical-grade brain monitoring and analytics outside traditional laboratory or clinical environments. Founded in collaboration with academic neuroscience experts and supported by organizations such as the National Science Foundation, Cogwear's mission is to provide scalable, real-time cognitive and mental health insights for medical, athletic, research, and commercial settings. Their technology platform employs advanced dry EEG sensors and machine learning algorithms for applications including early detection of Alzheimer's disease, behavioral health assessment, concussion monitoring, and neuromarketing analytics. The company is committed to meeting FDA requirements for medical-grade devices while expanding its impact through industry partnerships and scalable manufacturing.

LifeLens Technologies, Inc. is pioneering innovative devices for personal health monitoring, aiming to revolutionize healthcare through advanced physiological monitoring technologies that provide real-time health data to patients and healthcare professionals.

Bethel Biotech specializes in providing advanced genetic sequencing services and expert consultation to empower individuals and researchers with actionable genetic insights. Their mission is to make genetic information accessible and useful for personal health, wellness, and scientific advancement. By offering tailored solutions and ongoing innovation in automation, Bethel Biotech aims to drive forward the frontiers of genetic science and personalized medicine.

Kromek Group plc develops advanced detection technologies for radiological, nuclear, and biological threats using Cadmium Zinc Telluride (CZT) solid-state detectors. The company offers manufacturing and R&D for high-resolution gamma and neutron detectors, networked and wearable monitoring devices, and automated pathogen detection platforms. Its solutions serve the civil nuclear, medical, environmental, defense, and public health sectors worldwide, enhancing safety, operational efficiency, and health security.

Augmntr is a software and systems engineering company specializing in Augmented Reality and Virtual Reality technologies. We offer solutions for presenting real-time, real-world data to users in a hands-free, eyes-out interface, aiming to transform the way people and complex data sets interact.

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company aims to restore people's bodies and their self-belief by using technology to take the limits off living. With a commitment to medical education and improving patient outcomes, Smith+Nephew operates in over 100 countries and is dedicated to sustainability and community health. Their purpose is to promote health and wellbeing, not just through their products but also by ensuring a positive impact on society and the environment. Smith+Nephew is also committed to increasing diversity within the medical device industry through initiatives like the Orthopaedics for All global advisory board.

Kitware is dedicated to delivering innovation through advanced technical computing, state-of-the-art AI, and tailored software solutions. Founded in 1998, the company emphasizes an open-source philosophy, fostering collaboration and transparency to solve complex scientific challenges. Kitware is committed to advancing scientific understanding and improving technology through its extensive expertise in various domains, including AI and deep learning.

MediView XR, Inc. is a Cleveland, Ohio-based med-tech company pioneering the use of augmented reality (AR) and mixed reality to transform medical imaging, surgical navigation, and patient care. Their mission is to advance healthcare delivery with intuitive visualization, seamless collaboration, and evidence-based insights. MediView’s vision is to simplify, democratize, and inform healthcare delivery by unlocking the full potential of 3D data for image-guided procedures. Through partnerships with leading organizations such as GE HealthCare, Mayo Clinic, and Microsoft, MediView delivers AR-powered visualization and navigation solutions that provide clinicians with unprecedented 3D "X-ray vision," real-time collaboration, and improved procedural accuracy. The company is recognized for its innovative approach to addressing health equity by expanding access to advanced care, especially in rural and underserved communities. MediView’s technology is also making significant strides in medical education, enabling immersive, hands-on learning and remote collaboration for students and clinicians.

A-G Associates is a Service-Disabled Veteran-Owned and SBA 8(a) organizational consulting firm that specializes in high-impact strategy and implementation, data analysis and visualization, stakeholder engagement, and change management solutions. The company is dedicated to helping mission-driven organizations across federal, non-profit, and private sectors navigate meaningful process, culture, and strategic transformation for measurable impact. A-G Associates is recognized for its innovative approach and commitment to excellence, as evidenced by its inclusion in the Inc. 5000 list of fastest-growing private companies in America.

The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.

4TEEN4 Pharmaceuticals GmbH is a German biotech company pioneering precision medicine in critical care, with a mission to develop causal therapies for acute cardiovascular complications, particularly shock. The company focuses on targeting cDPP3, a key mediator in circulatory failure, and is advancing Procizumab, a first-in-class antibody, through clinical development. With a leadership team boasting over 150 years of pharma experience and a strong network of international researchers, 4TEEN4 aims to address unmet medical needs and improve patient outcomes where current therapies are inadequate.

GrayMatters Health is transforming mental healthcare by providing evidence-based technology that enhances standard-of-care therapies. Their flagship product, Prism for PTSD, is the first FDA-cleared self-neuromodulation device designed to help patients manage PTSD symptoms through innovative brain activity regulation techniques.

Parker University is a regionally accredited private university located in Dallas, Texas, offering a wide range of certificate, undergraduate, and graduate degree programs in healthcare and business-related fields. The university is committed to providing a culture of lifelong learning, research, and service, with a focus on patient-centric collaborative and conservative healthcare education. Parker University aims to transform lives by igniting passion and preparing students to become industry leaders through real-world experience and innovative learning environments.

VirtualMH, Inc. specializes in AI-powered virtual reality platforms designed to deliver trauma therapy using the Flash Technique. Serving government agencies, healthcare providers, first responders, clinicians, and consumers, the company provides scalable, HIPAA-ready, and clinically validated solutions for trauma resolution, with a focus on accessibility, privacy, and measurable clinical outcomes.

CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.

Michigan Engineering combines top-tier engineering education with advanced research and state-of-the-art facilities, supporting both undergraduate and graduate students. The college emphasizes hands-on and experiential learning, interdisciplinary collaboration, and research strengths in areas such as robotics, energy, sustainability, precision medicine, cybersecurity, space systems, and computational science. Advanced laboratories are available for internal and external users, reflecting a commitment to innovation, industry partnerships, and technology transfer.

Draper is an independent nonprofit engineering innovation company with a legacy spanning over 90 years, dedicated to delivering transformative solutions for national security, prosperity, and global challenges. Renowned for its pioneering work in guidance, navigation, and control (GN&C) systems, Draper partners with government, industry, and academia to engineer advanced technologies in space, defense, biotechnology, and electronic systems. The company leverages multidisciplinary expertise, digital engineering, and a collaborative approach to provide field-ready prototypes, mission-critical systems, and innovative research. Draper’s mission is to ensure the nation's security and prosperity by delivering sustainable, cutting-edge solutions that address the toughest problems of today and tomorrow, while fostering an inclusive and diverse workforce. Draper also invests in the next generation of innovators through robust educational programs, including internships, co-ops, and the Draper Scholars Program, integrating academic research with real-world problem-solving.

Modus Operandi is a high-tech software and information technology company headquartered in Melbourne, Florida, with over 40 years of experience. The company specializes in developing innovative Living Intelligence solutions that combine human expertise and machine analysis to deliver decision support for complex situations. Their mission is to empower organizations to make smarter, faster decisions by harnessing data and orchestrating advanced analytics. Modus Operandi serves a diverse clientele, including defense, intelligence, and commercial sectors, and is recognized for its commitment to quality, integrity, and customer success.

The University City Science Center (the Science Center) is a 501(c)3 non-profit organization based in Philadelphia, PA. The Science Center catalyzes innovation to maintain the technological superiority of the American military and the strength of the American economy. The Science Center’s core activities include programming to support and train entrepreneurs, commercialize dual use technologies, expand available capital for high growth firms, and cultivate the domestic STEM talent pipeline. We empower early-stage companies to secure and manage federal funding through specialized assistance. By leveraging our government relationships, providing comprehensive proposal development, and deploying sophisticated award management, the Science Center streamlines the process for startups in accessing federal funding. By ensuring that American scientific and technological innovations are rapidly advanced and integrated into defense and dual-use applications, the Science Center strengthens the US industrial base, enhances military readiness, and safeguards national security interests. This lab-to-market pipeline is critical to maintaining technological overmatch, securing supply chain resilience, and reinforcing biosecurity infrastructure. The Science Center’s innovation acceleration initiatives can directly contribute to the Department of Defense’s modernization priorities by reducing reliance on foreign technologies, fostering high-growth industries in critical technology areas, and ensuring that STEM advancements serve as strategic assets to protect and advance US interests. Since its founding, the Science Center’s commercialization and small business programming efforts have supported more than 700 companies, leading to 29,100 jobs with an average salary of $105,000 and $7.6 billion in annual economic impact in Greater Philadelphia. Through its commercialization programs, the Science Center has supported a range of mission-critical innovations that align with DoD priorities, including warfighter readiness, medical technology advancement, and operational resilience.

The Global Coalition for Adaptive Research (GCAR) is a 501(c)(3) nonprofit organization dedicated to accelerating the discovery and development of treatments for patients with rare and deadly diseases through innovative clinical trials, including master protocols and adaptive platform trials.

Areté, founded in 1976, is a leading science and engineering company dedicated to providing innovative solutions for national and global security challenges. The company excels in developing advanced sensing products and software, operating from the seafloor to space. Areté's mission is to harness world-class talent to deliver superior solutions, while its vision focuses on using leading-edge science and engineering to protect the nation and the world. The company is known for its creativity, integrity, passion, responsiveness, and collaboration, fostering a unique company culture that emphasizes employee growth and innovation.

Benchmark Biotech is a leading contract research organization focused on advancing medical device research and healthcare. Specializing in biotechnology and pharmaceutical development, the company supports the creation of innovative medical devices for trauma and combat casualty care. With a team of experienced scientists, specialists, and physicians, Benchmark Biotech is committed to improving patient outcomes through high-quality research and collaborative partnerships.

ARMR Sciences, Inc. is a biotechnology company dedicated to ending the fentanyl crisis and defending against synthetic drug threats through American innovation. The company is pioneering scalable, preventative immunotherapies to protect individuals before exposure to lethal synthetic drugs like fentanyl, moving beyond reactive treatments to address the root causes of overdose deaths. ARMR's technology is supported by foundational licenses from the Department of Defense and aligns with federal health and defense agencies. The multidisciplinary team brings significant experience from leading institutions and companies such as MindMed, iBio, Ridgeback Biotherapeutics, Scripps Research, Boston Children’s Hospital, Harvard Medical School, and more. United in their vision to save lives, ARMR is committed to providing lasting protection and solving the overdose crisis for millions in need.

Micron Biomedical is a clinical-stage life science company and the leader in dissolvable microarray-based technology for needle-free delivery of vaccines and therapeutics. The company's mission is to radically expand access to treatments and vaccines, improve global health outcomes, and transform how vaccines and drugs are administered. Micron's proprietary technology enables painless, thermostable, and self-administered drug and vaccine delivery, eliminating the need for cold chain logistics and reducing infrastructure barriers. The company is recognized for its innovative approach to overcoming vaccine hesitancy and access challenges, and is rapidly advancing toward commercializing its technology for global impact. Micron partners with leading global health organizations and has secured significant funding to accelerate the development and commercialization of its needle-free solutions.

InFlo Medical is pioneering the future of extracorporeal life support with the MOBYBOX - the world's first fully portable ECMO (extracorporeal membrane oxygenation) system. This breakthrough portable ECMO device weighs only 10 pounds and operates entirely on compressed gas power, delivering superior gas exchange performance in an ultra-compact, biocompatible design. The MOBYBOX portable ECLS (extracorporeal life support) technology represents a paradigm shift in emergency cardiac care, critical care transport, and point-of-care oxygenation. Unlike traditional bulky ECMO systems, our miniaturized ECMO solution enables rapid deployment in ambulances, helicopters, remote locations, and resource-limited settings where conventional extracorporeal membrane oxygenation is impossible. Key advantages of the MOBYBOX portable ECMO system include best-in-class oxygenation efficiency, reduced priming volume, lower pressure drop, enhanced patient mobility, and simplified operation - making advanced ECLS therapy accessible anywhere critical care is needed.

Spinal Stabilization Technologies, Ltd. is a medical device company specializing in the research, development, and manufacture of minimally invasive spinal medical devices, particularly focused on innovative nucleus pulposus replacement technology for treating degenerative disc disease and chronic low back pain. Founded in 2010 by interventional radiologists, the company develops surgical solutions that aim to preserve spinal function and natural motion, offering alternatives to traditional spinal fusion and total disc replacement.

KardioGenics is dedicated to transforming healthcare delivery through innovative technology, providing hospital-grade data anytime and anywhere with a focus on patient-centered care. Their solutions aim to eliminate geographical barriers in healthcare, ensuring timely access to critical cardiovascular data and enhancing the continuum of care through advanced AI-driven insights.

Aridica Corporation is dedicated to advancing immune system research and clinical applications by providing high-quality, automated immune cell isolation solutions. Their mission is to accelerate the development of diagnostics and next-generation therapeutics by simplifying and standardizing the process of immune cell separation. With a focus on automation, reliability, scalability, and sustainability, Aridica aims to empower researchers and clinicians to unlock the full potential of the immune system for improved health outcomes.

Temple University is Philadelphia’s only public university and a global center of academic excellence. It is classified as an R1 institution, indicating very high research activity, and offers over 600 academic programs across 17 diverse schools and colleges. The university is committed to providing accessible education that fosters positive change and prepares students to become leaders in their fields. Additionally, Temple emphasizes a vibrant campus life enriched by arts, culture, and a commitment to diversity and inclusivity. The university also promotes a tobacco-free environment to enhance the health and well-being of its community. Temple's athletics program further enhances student life, with 19 varsity teams competing at the NCAA Division I level, fostering school spirit and community engagement.

The Office of Sponsored Projects Administration (OSPA) at the University of Kentucky is dedicated to transforming tomorrow by streamlining grants and contracts. OSPA provides essential services to faculty and staff, including assistance with proposal preparation, award negotiation, and compliance with sponsor policies.

Credence Management Solutions, LLC is a leading technology-driven management consulting firm serving government and defense clients. With a mission powered by technology, Credence delivers innovative solutions in AI, cloud, cybersecurity, data, enterprise modernization, and blockchain to support critical missions in national security, health, and federal operations. The company is a prime contractor on a wide array of major government contract vehicles, including GSA OASIS, GSA MAS, DLA JETS 2.0, GSA ASTRO, CDAO AI Talent 2.0, Army ITES-3S, Navy SeaPort-NxG, and more, enabling flexible and rapid engagement with federal clients. Credence is recognized for its agility, robust partnerships, and a culture rooted in servant leadership, trust, and continuous professional growth. The company’s vision is to empower clients, employees, and partners to achieve success together, while maintaining a strong commitment to corporate citizenship and community support.

Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

GenVault operates a secure, large-scale biorepository specializing in the storage, management, and logistics of biological and sensitive materials. Serving the life sciences, healthcare, government, and research sectors, GenVault offers robust, regulatory-compliant infrastructure engineered for resilience. The facility supports a comprehensive range of temperature-controlled storage and provides integrated sample management, cold chain logistics, and laboratory relocation services. Quality is maintained through internationally recognized certifications, advanced security systems, and a mature governance structure that emphasizes continuous compliance and operational transparency.

OxiWear is a patient-led medtech company based in Arlington, VA, founded in 2019 by Shavini Fernando. The company is dedicated to reducing patient vulnerability to hypoxic injury through wearable, continuous oxygen monitoring, aiming to increase safety and security for those prone to silent hypoxia, reduce healthcare costs, and save lives. OxiWear's mission is rooted in empowering individuals with chronic conditions to live life to the fullest, leveraging cutting-edge technology to deliver medical-grade, real-time health data. Their FDA-cleared, ear-wearable pulse oximeter is designed for both clinical and at-home use, providing accurate, second-by-second blood oxygen and pulse rate monitoring across all skin tones and during motion. OxiWear is recognized for its innovation, patient-centric approach, and commitment to health equity.

Aspen Medical is a global leader in innovative healthcare solutions, specializing in delivering high-quality healthcare services in remote, challenging, and under-resourced environments. Established in 2003 in Australia, the company operates across Australia, the UK and Europe, the Middle East, North America, Africa, Asia, and the Indo-Pacific region. Aspen Medical is the only commercial organization in the world certified by the World Health Organization as an Emergency Medical Team for infectious disease outbreaks and trauma surgical operations. The company is committed to social responsibility, diversity, and inclusion, and is a certified B Corp and a signatory to the United Nations Global Compact. Aspen Medical partners with governments, NGOs, and private sector clients to provide end-to-end healthcare solutions, including hospitals and clinics, health advisory services, humanitarian and disaster response, aeromedical retrievals, occupational health, training, health technology, aged care, and medical equipment supply. The Aspen Medical Foundation, the company's registered charity, supports scholarships, community partnerships, and philanthropic initiatives, with a focus on empowering healthcare workers and communities.

BioFactura, Inc., based in Frederick, Maryland, is a biopharmaceutical company specializing in the development and commercialization of high-value biosimilars, biodefense medical countermeasures, and novel drugs. Leveraging its proprietary StableFast™ Biomanufacturing Platform, BioFactura delivers faster, lower-cost, and superior-quality biologics. With over a decade of experience, the company has advanced life-saving medicines from research to patient care, focusing on unmet global biomedical and national biodefense needs. Its portfolio includes drugs for smallpox, Ebola, cancer, autoimmune, and infectious diseases.

HNu Photonics is a Hawai’i-based science and technology company specializing in the research, design, fabrication, and assembly of advanced photonics, optics, and instrumentation technologies. The company provides integrated solutions across biotech, defense, energy, and advanced manufacturing sectors, offering vertically-integrated services from concept development to finished products. Areas of focus include renewable energy systems, defense photonics, specialized optics, and medical imaging technologies.

Torpedo Therapeutics is dedicated to advancing the field of neurological disorder treatment through high-precision, closed-loop deep brain stimulation (DBS) therapy. Their mission is to enhance the efficacy and safety of DBS by innovating electrode technologies and developing automated data analysis platforms. This approach aims to minimize side effects and improve long-term outcomes for patients with conditions such as Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy.

Combat SNS (Combat Medical Consulting, CMC) is a Service-Disabled Veteran-Owned Small Business (SDVOSB) dedicated to bridging the gap between innovative medical technologies and operational end users in the Department of Defense (DoD), Department of Veterans Affairs (VA), and other government agencies. With over 30 years of expertise in direct sales, government procurement, and market integration, CMC specializes in high-quality medical supply distribution, consulting, and product development. Their mission is to accelerate the adoption of advanced medical solutions, ensuring best-value procurement and broad impact across public health and defense sectors. CMC is recognized for its comprehensive approach, from market research and product validation to training, certification, and field deployment.

Quadridox, Inc. is a pioneering company merging physics with computation to revolutionize X-ray technology for a safer, healthier, and more informed world. Founded in 2018 and headquartered in Hillsborough, North Carolina, Quadridox develops state-of-the-art X-ray tools and technologies, including advanced simulation, synthetic data generation, and X-ray diffraction imaging systems. Their multidisciplinary team of experts delivers innovative software and hardware solutions for security, medical, and industrial applications, serving both government and commercial clients. Quadridox is committed to advancing X-ray system design, analysis, and validation, with a mission to enable rapid, accurate, and cost-effective detection and diagnosis across industries.

ALA Scientific Instruments, Inc. is dedicated to advancing life science through innovative instrumentation. With over thirty years of experience, the company provides researchers with the tools necessary for challenging experiments in biophysics and cellular electrophysiology.

JURA Bio is pioneering AI-native drug discovery by bridging the gap between computational design and physical reality in biological AI. Their mission is to revolutionize the discovery and development of safe and effective drugs, making even the hardest therapeutic targets tractable. By leveraging manufacturing-aware generative models, JURA Bio not only designs new therapeutics but also builds, tests, and learns from them at unprecedented scale. Their approach integrates machine learning, synthetic biology, and high-throughput experimentation to create a new paradigm in drug discovery, where AI learns from tens of billions of real protein interactions and every candidate is inherently human-safe.

NTx Bio (Nature’s Toolbox, Inc.) is revolutionizing biomanufacturing by enabling on-demand, decentralized, and scalable production of high-quality RNA and proteins. Our mission is to democratize access to medicines by overcoming the bottlenecks of traditional, centralized manufacturing. Through proprietary, synthetic biology platforms like NTxscribe® (mRNA production) and NTxpress® (cell free protein production), NTx empowers researchers and companies to accelerate the development and delivery of personalized and mass-scale therapeutics, making next-generation medicine more accessible, sustainable, and efficient, while eliminating supply chain concerns by using 100% domestic inputs and production capabilities.

Celestial Therapeutics is a Johnson & Johnson Innovations-JLABS resident California-based biotechnology company focused on developing innovative therapies to treat, prevent, and cure infectious diseases, rare diseases, and cancers. The company leverages groundbreaking science to create dual-modal antivirals/anti-inflammatories, mRNA vaccines, and therapeutics. Founded in 2019, Celestial has rapidly built a diverse portfolio based on its innovative innate immunity platform technologies, aiming to address significant unmet medical needs worldwide.

The University of Louisville Office of Research and Innovation is a premier metropolitan research institution dedicated to advancing knowledge, fostering creativity, and driving innovation across diverse disciplines. Its mission is to support research, scholarship, and creative activity, translating UofL discoveries to benefit Louisville, Kentucky, the nation, and the world. Recognized as a top-tier 'Research 1' university, UofL supports a vibrant ecosystem of research centers, institutes, and collaborative initiatives spanning medicine, engineering, business, and the arts. The office provides robust support for postdoctoral fellows, industry partnerships, entrepreneurship, and access to state-of-the-art core facilities and research tools, making it a hub for innovation, technology transfer, and startup development. UofL is committed to the highest standards of research integrity, compliance, and ethical conduct, ensuring responsible and impactful research outcomes. The office offers comprehensive resources for research participants, including specialized support for children in research, and maintains a strong focus on research policies, technology licensing, industry collaboration, and researcher development through training and funding opportunities. UofL's vision is to support ideas that change, improve, and even save lives, continuously raising the bar for research excellence and societal impact. The office is structured to provide specialized support through dedicated units, research deans, and operational teams, ensuring efficient management and advancement of the university's research enterprise. UofL also maintains transparent and federally compliant practices for indirect cost recovery, ensuring full cost recovery for sponsored projects and providing clear guidance on budget and financials for researchers and partners.

IntelliGenesis LLC is a veteran- and woman-owned small business headquartered in Columbia, Maryland, with additional offices in Georgia and Texas and presence in Hawaii, Utah, and Colorado. Since 2007, the company has specialized in analytics development, artificial intelligence (AI), machine learning (ML), and training services, primarily supporting the Department of Defense (DoD), Intelligence Community, and commercial clients. IntelliGenesis is recognized for its mission-focused approach, innovation in AI/ML, and commitment to a culture of learning and career development. The company is dedicated to advancing national security and empowering organizations with cutting-edge AI-driven cybersecurity solutions, such as CYBERSPAN® and KrakenAI™, and is known for its strong support of transitioning military personnel and investment in employee growth.

Sempulse is a pioneering company that empowers medical professionals with advanced non-invasive monitoring technology. Their flagship product, the Halo Vital Signs Monitor, allows for real-time tracking of multiple patients' vital signs from a single device, enhancing patient care and operational efficiency in various healthcare settings. Sempulse's mission is to improve patient outcomes through innovative technology that integrates seamlessly into existing healthcare systems.

Persist AI is a biotechnology company pioneering the use of AI-driven robotics to accelerate and transform pharmaceutical formulation development. Their mission is to deliver life-saving drugs faster, with fewer side effects, and improved patient outcomes by leveraging advanced automation, machine learning, and high-throughput experimentation. Persist AI's integrated platform addresses the bottlenecks of traditional drug formulation by combining custom robotics, computational chemistry, and proprietary AI models, enabling rapid, scalable, and cost-effective development of complex drug delivery systems such as long-acting injectables. With a global presence and a team of experts in drug delivery, automation, and machine learning, Persist AI is committed to making advanced drug delivery systems more accessible and efficient for the pharmaceutical industry worldwide. The company also demonstrates a strong commitment to data protection, privacy, and security, implementing robust technical and organizational measures in compliance with international standards.

Paragraf specializes in the development and manufacture of wafer-scale, silicon-compatible graphene electronic devices and sensors. Utilizing a proprietary process for direct, contamination-free graphene synthesis, the company delivers scalable solutions for magnetic field sensing, molecular and biosensing, and advanced electronics integration. These technologies address challenges in cryogenics, quantum computing, automotive, aerospace, environmental monitoring, and healthcare. With a focus on large-scale integration of 2D materials, Paragraf advances next-generation sensors and components for demanding and extreme environments.

PulpDigital.ai, founded in 2024, is a healthcare technology innovator dedicated to transforming patient care through advanced artificial intelligence solutions. Their mission is to harness AI to solve healthcare's most complex challenges, empowering providers and improving patient outcomes with innovative, accessible, and ethical technology. The company envisions a world where AI-powered healthcare is seamlessly integrated into clinical workflows, extending provider reach, enhancing patient engagement, and making quality care accessible to all. PulpDigital.ai is guided by values such as patient-first innovation, ethical AI development, collaborative excellence, data privacy, continuous improvement, and global impact. Their approach combines deep healthcare expertise with cutting-edge AI, focusing on real-world challenges and rigorous solution development.

Pennington Biomedical Research Center, a campus of the LSU System, is a global leader in medical discovery and translational science. Pennington Biomedical is dedicated to understanding the biological triggers of disease and nutrition-related conditions. Through basic, clinical, and population research, Pennington Biomedical pursues a bold vision: to lead the world in promoting nutrition and metabolic health and eliminating metabolic disease through scientific discoveries that deliver solutions from cells to society. Building on this foundation, Pennington Biomedical has become a trusted partner in human performance science, with over 30 years of collaboration with the Department of War and a legacy of more than 170 military-focused research projects. This expertise now extends to spaceflight, where Pennington Biomedical seeks to address the physiological demands of long-duration missions. At the forefront of these efforts is the Center for Human Performance Optimization, which unifies military and spaceflight performance science to drive cross-domain innovation. The Center conducts multidisciplinary research to understand and enhance human capabilities under extreme stress. Research spans clinical trials, operational studies, and advanced analytics, with integrated approaches across nutrition, exercise, sleep, pharmaceuticals, cognitive health, and emerging technologies. Studies focus on preventing performance decline and pushing the boundaries of human potential in the harshest environments. Pennington Biomedical’s world-class infrastructure supports this mission. The Clinical Trials Unit includes a 90,000-square-foot outpatient clinic, a 20-bed inpatient unit with metabolic chambers and sleep labs, a metabolic kitchen, dedicated exercise facilities, and flexible-use research space. These resources enable rigorous, multidisciplinary trials. The CTU is further supported by advanced imaging, biochemistry, and data management cores, as well as animal research platforms focused on metabolism, behavior, and comparative biology. Through its integrated platforms and mission-driven focus, Pennington Biomedical is shaping the future of human performance science. The Center for Human Performance Optimization delivers real-world impact for national defense, space exploration, and elite human capability—ensuring warfighter readiness, astronaut resilience, and human excellence across the most challenging environments.

Cepheid is a global leader in molecular diagnostics, dedicated to improving healthcare by developing, manufacturing, and marketing automated, easy-to-use molecular systems and tests. Their mission is to provide rapid, accurate, and actionable genetic testing for a wide range of infectious diseases, oncology, and human genetics. Cepheid's flagship GeneXpert System delivers scalable, sample-to-answer PCR testing for institutions of any size, supporting both centralized and decentralized care. The company is committed to expanding access to high-quality diagnostics worldwide, supporting public health initiatives, driving innovation in molecular testing, and advancing sustainability and responsible business practices.

The Israel Innovation Authority is the central governmental body responsible for fostering and advancing Israel's innovation ecosystem. Its mission is to power innovation through investment, insight, and impactful programs, supporting high-tech entrepreneurship, deep-tech ventures, and global collaborations. The Authority provides non-dilutive funding, strategic support, and regulatory guidance to startups and established companies, ensuring Israel remains a global leader in technology and innovation. With a focus on sectors such as AI, bioconvergence, foodtech, climate tech, and more, the Authority bridges academia, industry, and international partners to address humanity's pressing challenges and drive economic growth. Israel's tech ecosystem, often called the "Startup Nation," is characterized by a culture of bold experimentation, interdisciplinary collaboration, and resilience, making it a global powerhouse for innovation. The Authority also plays a pivotal role in shaping national innovation policy, supporting R&D, and facilitating co-investment opportunities for international investors. The Authority's unique features include proactive future-readiness, risk-absorbing investment models, global market integration, and resilience in times of crisis, such as the deployment of Fast-Track bridging funds to protect startups. The Authority also operates innovation centers and manufacturing accelerators to expand high-tech opportunities geographically and demographically, and regularly identifies and supports emerging technologies with high potential impact. The Authority supports a vast portfolio of startups and scale-ups across diverse sectors, including medical engineering, software, electronics, foodtech, biotech, and more, through programs such as Tnufa, Technological Incubators, R&D grants, and international collaborations.

Prescient Healthcare AI is revolutionizing healthcare delivery through its innovative AI Care Platform, designed to alleviate the economic burden of poor health on US employers and improve patient outcomes. By leveraging advanced artificial intelligence, the platform delivers timely, personalized health insights and interventions, proactively managing chronic diseases and reducing emergency room visits. Prescient Healthcare AI integrates real-time data, such as air quality and environmental factors, to empower individuals and organizations to make informed health decisions, resulting in significant cost savings and improved wellness. The company is committed to seamless integration, user engagement, and a proactive approach to healthcare, making it an ideal partner for sustainable, efficient, and patient-centered care.

AvantGuard has developed a novel broad-spectrum, bio-compatible antiseptic that is proven in in vitro, ex vivo, and in vivo testing to be safe and more effective than topical antibiotics, while also effective as a liquid sterilant or disinfectant. Our compound, Avantamine, can be packaged as a heat-tolerant, long-shelf-life powder in a metal foil packet that dissolves rapidly in potable water to make either a solution or hydrogel. At a high concentration, Avantamine's non-hazardous, non-corrosive solution will sterilize medical equipment in 10 minutes and is safe enough for instruments to be removed and used without rinsing. Diluted by half, Avant24 at 0.6% concentration is (1) an antiseptic for washing wounds or treating cutaneous bacterial and fungal infections, (2) a high-level disinfectant for a variety of medical devices without corroding metals or degrading plastics, and (3) a disinfectant for surfaces in the surgical suite. At 6X further dilution, Avant24 can treat trench mouth. At another 3X dilution, Avant24 can be added to water to make it drinkable. There are an enormous number of potential uses and the only difference between them is the amount of diluent, in this case water, used to prepare the solution. Our military focus areas are (1) low resource sterilization of medial devices, (2) fungal treatment for burn wounds, and (3) a prophylactic for infection control in a self-administered Role 1 environment with the powder applied directly to a wound. Our commercial focus area is Candida auris decolonization which is not currently possible with any other antiseptic. We have definitive animal testing to show efficacy and superiority to chlorhexidine and are moving toward the clinic.

Molecular You is a pioneer in predictive, preventative, and precision health, providing advanced molecular analysis to empower individuals and healthcare providers with actionable health insights. Founded in 2014 as a spin-off from the Personalized Medicine Initiative in Vancouver, BC, the company leverages cutting-edge proteomics, metabolomics, and AI to analyze over 250 blood-based biomarkers. Their mission is to make molecular medicine simple, accessible, and impactful, enabling early detection of disease risks and supporting personalized, data-driven health decisions. Molecular You serves both clinics and individuals, offering comprehensive health assessments, personalized action plans, and ongoing progress tracking to foster proactive, transparent, and preventative care. The company’s platform is rooted in rigorous scientific validation, peer-reviewed research, and advanced multi-omic analysis, setting a new standard for precision health and population health management. Molecular You’s unique systems biology approach analyzes interconnected pathways—such as metabolic, cardiovascular, immune, neurological, and hormonal health—providing a holistic view of health that goes far beyond traditional lab tests. Their direct-to-consumer platform enables at-home blood draws and digital health dashboards, and their Action Plan translates biomarker data into tailored, science-backed recommendations for diet, supplements, and lifestyle. The platform’s comprehensive biomarker coverage and AI-driven insights empower both patients and providers to detect and address health concerns long before symptoms arise.

The Southwest Texas Regional Advisory Council (STRAC) is dedicated to developing, implementing, and maintaining a regional trauma and emergency healthcare system for the 22 counties in Trauma Service Area – P. STRAC aims to reduce death and disabilities related to trauma, disaster, and acute illness through well-coordinated emergency response systems, striving to be a model for emergency healthcare in the United States.

NakedHealth.ai is dedicated to empowering individuals to take control of their health through transparent, AI-driven insights tailored to personalized decisions. The company is committed to equity in healthcare, providing free Electronic Health Records (EHR) services to hospitals in developing regions, and fostering an informed community with open access to healthcare. Their mission is to demystify health complexities, promote transparency, and ensure everyone has access to quality, personalized healthcare. NakedHealth.ai is also focused on innovation, compliance with international standards, and robust security for health data.

Paracrine develops regenerative therapies for chronic wound care, leveraging autologous cell-based treatments and real-time AI platforms to enhance healing precision, predictability, and efficiency. The company operates globally, focusing on scalable and cost-effective biological solutions that integrate advanced machine learning for improved patient outcomes.

North American Rescue (NAR) is dedicated to decreasing preventable death by providing the most effective and highest quality mission critical medical products to military, federal agencies, civilian law enforcement, EMS, and pre-hospital life savers. NAR designs, develops, and tests products based on Tactical Combat Casualty Care (TCCC) guidelines, ensuring they meet the evolving needs of first responders and healthcare providers. NAR is committed to quality, with a focus on American-made products and adherence to the highest industry standards.

The University of Arizona Applied Research Corporation (UA-ARC) is a non-profit organization affiliated with the University of Arizona, dedicated to leveraging the university's strengths in research and education to address national security challenges. UA-ARC aims to deliver innovative solutions and foster collaborations between academia, industry, and government.

ANT5 Co., Ltd. is a startup originating from Yamaguchi University dedicated to the research and development of medical devices for patients suffering from severe brain diseases. The company aims to save lives and alleviate suffering through advanced technology, with a vision to become the global standard in sensor and cooling technology for brain disease treatment by 2030.

Frontier Bio creates lab-grown human tissues to reduce the worldwide organ shortage. Their first clinical product is a tissue-engineered vascular graft made from the patient's own cells.

NEUROFIT (Xama Technologies, Inc.) is a U.S.-based digital health company delivering AI-guided somatic nervous system regulation for rapid stress recovery. The NEUROFIT mobile app uses a proprietary 8-domain psychometric assessment (NF8) to personalize nervous system coaching and somatic release exercises in 5-minute daily sessions - achieving therapy-level outcomes without a clinician. Independent MMRM analysis (n=16,487) by a Harvard Medical School biostatistician demonstrates 39% stress reduction at Day 7 (Cohen's d=0.80) and 52% sustained reduction at Day 35. The NF8 assessment is validated against PHQ-9, GAD-7, and DASS-21. Deployed commercially with 115,000+ downloads across 100+ countries, 800+ trained health professionals, and zero adverse events. NEUROFIT is seeking DoD and VA partnerships to extend its evidence base and impact to military populations, with particular focus on SOF stress recovery, PTSD prevention, and force preservation.

The University of Utah (UU) is a leading research institution recognized for its research activity and commitment to innovation and discovery. As an R1 Institution, it is dedicated to advancing knowledge and solving critical problems that challenge our national security interests and impact the global community. We foster interdisciplinary collaboration and provide resources to drive transformative research focused on enhancing medical care superiority for the U.S. Department of Defense (DoD) through advanced medical and engineering research sponsored by our Applied Medical & Engineering Laboratory (AM&E Lab). As a leading public university, UU also provides healthcare services to seven states in the Intermountain West, with the largest catchment of remote and austere frontier territory for any academic center. Leveraging its geographic advantage, technological and commercialization strengths, expertise in medical services, and leading-edge, core engineering competencies, UU is uniquely positioned to address the nation's critical national security interests.

LenioBio GmbH develops scalable eukaryotic cell-free protein expression technologies enabling rapid and flexible production of complex proteins. Its proprietary platform facilitates expression of membrane proteins, antibodies, virus-like particles, and proteins with complex post-translational modifications, supporting applications from research to biomanufacturing and vaccine development. The technology addresses key bottlenecks in traditional protein production, offering fast turnaround, batch consistency, and the potential for integration with rapid DNA template synthesis. LenioBio collaborates with leading industry partners and continually advances its platform for broad accessibility and application in life sciences.

BIAGNOSIS specializes in developing advanced psychological diagnostic tools that leverage machine learning and business intelligence. With a foundation in extensive clinical and research experience, the company aims to help organizations optimize business performance by reducing pressures and barriers, enhancing resources, and improving the wellbeing of both employees and customers. Their vision is to bridge human complexity and technology to create flexible, research-based solutions for the modern workplace.

Johnson & Johnson Innovation is dedicated to advancing healthcare innovation through partnerships, venture investing, and incubation. They focus on MedTech and innovative medicine, aiming to foster early-stage innovation and support entrepreneurs in the healthcare sector.

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

StethX is a Georgia Tech spin-off developing Dual-Use technologies, Alt-PNT and AI powered wearables. The company is dedicated to advancing cardiovascular and pulmonary healthcare through innovative, wearable medical devices that capture the acoustic fingerprints of the heart and lungs. By leveraging precision wearable technology, machine learning, and artificial intelligence, StethX aims to provide real-time, customized data for patients and clinicians, enabling informed treatments and improved outcomes. Their mission is to make healthcare more accessible, efficient, and personalized, ensuring everyone has access to high-quality, patient-centered care.

Inflammasense specializes in advancing healthcare and clinical research through the integration of neural and molecular biomarkers. By leveraging continuous, real-time physiological and molecular data, the company aims to facilitate precision treatments, accelerate clinical trials, and enhance early detection and prevention of critical illnesses such as sepsis and hemodynamic compromise. Their technology platforms including the wearable VITALX-PATCH system that supports clinical trials, defense, and corporate wellness sectors, with a focus on expedited objective decision-making and scalability. The company has secured $4.05 Mil in non-dilutive funding from DARPA, BARDA and the NIH, while it has now closed a total of 1.65 Mil in dilutive funding from KittyHawk Ventures (Pre-seed of $250K) and private investment of (Seed $1.5 Mil). The 2 years long Pre-Seed funding is scoped to obtain FDA 501 (k) clearance of the VITALX-PATCH and complete the in process FDA submission. InflammaSense is seeking $7.5 Mil investment for the clinical trials and product manufacturing to scale for DeNovo approved devices. The approved device is indicated for the first beach head use case as a companion diagnostic for individualized Sepsis therapy.

OrthoBarrier Technologies, LLC is a Colorado-based medical device company focused on eliminating preventable infections associated with percutaneous orthopedic pins and external fixation systems. The company aims to establish a new standard of care in orthopedic infection prevention by developing engineered antimicrobial dressings, addressing a long-standing clinical need where improvised dressings are currently used. The mission is to protect patients at the hardware-skin interface through reliable, clinically proven, and engineered solutions.

Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.

The University of Minnesota's Research and Innovation Office (RIO) serves as a central resource for conducting, managing, and sponsoring research. It aims to facilitate collaborative research that addresses complex problems and promotes innovations that improve lives. RIO oversees research compliance and administration, fostering a culture of integrity and ethical practices in research. Additionally, RIO is committed to enhancing research capacity through various funding opportunities and strategic initiatives, including the management of specialized facilities for biocontainment research.

TIAG is an innovative technology company providing strategic, transformational solutions to private industry and across the Department of Defense. With a focus on agility and ingenuity, TIAG addresses complex challenges through a range of services including cloud migration, cybersecurity, data analytics, and human-centered design. The company prides itself on its commitment to excellence and its ability to deliver results that exceed client expectations.

The Wyss Institute for Biologically Inspired Engineering uses biological design principles to develop new engineering innovations that will transform medicine and create a more sustainable world. At the Wyss Institute, we leverage recent insights into how Nature builds, controls and manufactures to develop new engineering innovations - a new field of research we call Biologically Inspired Engineering. By emulating biological principles of self assembly, organization and regulation, we are developing disruptive technology solutions for healthcare, energy, architecture, robotics, and manufacturing, which are translated into commercial products and therapies through formation of new startups and corporate alliances.

Exo Insights offers data-driven solutions for training optimization in high-risk and high-stakes environments. The company's system employs biosensors, motion tracking, and analytics to automate instructor tasks, standardize assessments, and deliver real-time objective feedback during training. Their platform focuses on improving performance, enhancing safety, and increasing operational efficiency for training at scale.

Rattler Medical Solutions focuses on advancing healthcare technology for environments with limited resources. The company provides lightweight, low-power devices that extend the shelf life of biologic products, supporting prolonged field care and resupply in far-forward operations. The mission centers around creating biologic solutions that enhance medical personnel's capabilities in both civilian and operational settings.

SurgiBox Inc. is transforming surgical care with award-winning, patented technology designed to make safe surgery possible anytime, any place. Our flagship product, SurgiField, is an ultra-portable, battery-powered solution that enables safe, clean surgical conditions - from private clinics to the most hard-to-reach austere settings, namely disaster and conflict zones. Built on years of research and collaboration with leading clinicians, SurgiField integrates seamlessly into existing surgical workflows and meets the highest regulatory standards, including CE Mark under EU MDR, ISO 13485 compliance and approval in Japan. Pending regulatory approval in Taiwan, UAE, KSA, and Türkiye. Founded by Harvard Medical School-educated clinicians and incubated at MIT D-Lab, SurgiBox is committed to making surgery safer, more accessible, and more adaptable worldwide.

Proove Genomics is a leader in predictive health, utilizing advanced genetics and information technology to revolutionize medical decision-making. Their approach focuses on predicting and preventing health issues, thereby enhancing treatment outcomes and reducing healthcare costs. Proove's predictive healthcare model is supported by a vast clinical data bank, aiming to address major health challenges and reduce the leading causes of death.

Case Western Reserve University is dedicated to solving the biggest issues of today and tomorrow through innovative research and education. With a commitment to experiential learning, the university offers a wide range of programs and opportunities for students to engage in research, internships, and community service, all within a vibrant campus located in Cleveland, Ohio.

The Henry M. Rowan College of Engineering at Rowan University is a leader in engineering education, research, and innovation. With a mission to advance fundamental and applied science and engineering technology, the college emphasizes responsible use of both renewable and fossil resources to enhance material performance and global sustainability. The college fosters a diverse, collaborative environment that educates and trains the next generation of scientists and engineers, while engaging in impactful research, industry partnerships, and community outreach.

AiRANACULUS is a leader in Intelligent RF and Networking Solutions, providing advanced technologies for applications from Space to Smart Cities. The company focuses on creating spectrum-aware technologies that optimize radio and sensor systems for performance in complex environments, leveraging expertise in signal processing, cybersecurity, and networking.

Versiti is a nonprofit, 501(c)(3) blood health organization dedicated to improving patient lives and supporting healthcare partners through blood donation, innovative research, and advanced diagnostic testing. With locations across the Midwest, Versiti is a leader in blood health innovation, organ and tissue donation, and precision medicine. The organization is committed to enhancing patient care, advancing healthcare standards, and fostering a vibrant donor community. Versiti also supports education through scholarships and is recognized for its compliance and accreditations.

The Wireless Research Center (WRC) is an independent, private nonprofit research center based in North Carolina’s Research Triangle region. Since 2010, WRC has advanced global innovation in wireless connectivity through applied research, engineering, and certified testing. WRC supports clients worldwide, helping develop and commercialize wireless products from concept to high-volume production. The organization is recognized for its unique intellectual property policy, allowing clients to retain full ownership of jointly developed IP. WRC’s core initiatives—WRC Technologies, RIoT, Connected Communities, and the Advanced Mobility Collective—focus on improving wireless technologies, accelerating startups, supporting entrepreneurs, and fostering technology-led economic development. WRC is a catalyst for collaboration among local governments, schools, companies, and global partners, integrating technology and innovation into communities to improve lives and bridge the digital divide.

Cloudera, Inc. is a global leader in enterprise data cloud solutions, empowering organizations to transform complex data into actionable insights. With a mission to make what is impossible today possible tomorrow, Cloudera delivers a true hybrid data, analytics, and AI platform for any data, anywhere—from the Edge to AI. The company is driven by open-source innovation and is dedicated to advancing digital transformation for the world’s largest enterprises, providing secure, governed, and scalable solutions across hybrid and multi-cloud environments. Cloudera serves a diverse range of industries, including healthcare, financial services, manufacturing, telecommunications, public sector, and more, enabling customers to tackle transformational use cases and drive value through real-time insights. Cloudera is also a vocal advocate for open standards in machine learning operations and governance, and partners with leading organizations to deliver secure, data-driven innovation worldwide.

Signum Technologies is dedicated to leveraging cutting-edge computer vision and artificial intelligence to enhance health and safety. The company focuses on developing innovative solutions that address critical challenges in healthcare and security, aiming to create a safer and healthier future for society.

Polaroid Therapeutics is a Swiss-based biotech start-up, established in 2022 and incubated by the iconic Polaroid brand. The company is dedicated to addressing major challenges in antimicrobial therapies through cutting-edge technology and research. Its mission is to create a more human, meaningful, and healthier world by developing proprietary antimicrobial polymer technologies that reduce bioburden, improve patient outcomes, and do not trigger antimicrobial resistance (AMR). Polaroid Therapeutics focuses on advanced wound care, medical device coatings, and holistic therapeutic applications, aiming to set new standards in patient-centric care and global health.

CRG Defense is a secure, scalable defense company, purpose-built for rapid deployment of defense and dual-use technologies into field-ready systems. From prototype to production — CRG Defense delivers mission-critical innovation across systems, materials, power, infrastructure, and medtech. Our Vision is a world where advanced defense capabilities strengthen national security, empower warfighters, and preserve freedom through innovation. Our Mission is to design, develop, and deliver solutions that serve the warfighter, support our partners, and scale to meet the future of national defense. Our Technology Innovation Division develops solutions in advanced aerospace, materials, AI, energy systems, and human health technologies, transforming emerging science into mission-ready capabilities.

Medmarc, established in 1979 by the healthcare technology industry, is dedicated to providing superior liability insurance protection and risk management solutions to the life sciences and medical technology sectors. The company supports the development, testing, and delivery of medical products that enhance and save lives. Through collaboration with its parent company, ProAssurance, and strategic alliances, Medmarc offers innovative healthcare liability insurance solutions tailored to the evolving needs of life sciences companies.

Spectral Platforms is pioneering rapid diagnostic solutions in clinical microbiology, focusing on eliminating time-consuming steps in traditional microbiology to enable faster, more accurate detection and characterization of pathogens. Their proprietary technology leverages sensitive detection of bacterial metabolites and redox state changes, providing results in minutes rather than days. The company aims to improve patient outcomes, particularly in sepsis and infectious disease management, by delivering rapid, reliable, and actionable diagnostic information. Spectral Platforms also offers advanced microbiology services and collaborates with leading institutions and regulatory bodies to validate and deploy their innovations.

Auric Innovations develops emergency medical technologies focused on hemorrhage control, casualty monitoring, and trauma care in both civilian and military environments. The company designs and manufactures medical devices and training systems, including advanced tourniquet platforms, hemorrhage control simulators, and wearable biosensor technologies. Current development efforts include patented networked tourniquet systems capable of transmitting location and physiological data to responders, enabling real-time casualty awareness, automated alerts, and improved decision support during prehospital and battlefield care. Integrated AI models analyze sensor and operational data to assist with triage, injury assessment, and responder decision-making in time-critical environments. Auric Innovations’ technologies are designed for dual-use deployment across military medicine, emergency medical services, law enforcement, and disaster response.

Triton Genomics develops portable, field-deployable systems for automated preparation of DNA and RNA libraries used in next-generation sequencing (NGS). The company's technology is designed to function reliably in challenging field conditions and to enable rapid, user-friendly, and safe sample processing at the point of collection. Triton Genomics aims to democratize access to advanced genomic analysis for both scientists and non-scientists across diverse application areas such as public health, environmental monitoring, and forensic science.

ClearCure Biosciences is a clinical-stage biopharmaceutical company focused on developing non-toxic, first-in-class and best-in-class therapies for cancer, infectious diseases, sepsis, neurological diseases, and cardiovascular conditions. The company emphasizes drugging challenging targets, leveraging proprietary small molecules, nanotechnology, new oncology cell therapies, new transdermal drug delivery technology, AI and omics-driven approaches, and digital health solutions to address serious unmet medical needs. The company is currently seeking collaborators and partnerships.

AeroVironment designs, develops, and deploys uncrewed aerial, ground, and loitering munitions systems, as well as advanced autonomy and mission software for defense, security, and exploration applications. The company has a track record of pioneering innovations in robotics, high-altitude platforms, and planetary flight systems, delivering scalable and adaptable technologies for complex and demanding missions across multiple domains.

Modulim is dedicated to preventing the complications of chronic wounds due to diabetes, peripheral arterial disease, and burns. Mapping tissue health at the point-of-care is key to preventing non-healing chronic wounds. This is made possible only by Modulim's handheld microvascular imaging solution, powered by Spatial Frequency Domain Imaging (SFDI), that empowers healthcare teams with proprietary data and proactive, personalized AI insights.

BrainHQ is a leading brain training platform developed by top neuroscientists, designed to enhance cognitive functions through scientifically proven exercises. It offers a flexible and personalized approach to brain fitness, adapting to individual needs and lifestyles, and is backed by extensive research demonstrating its effectiveness in improving memory, attention, and overall brain health. The platform also provides classes and webinars to educate users on brain health and cognitive training. With over 100 published studies validating its benefits, BrainHQ continues to evolve through ongoing research.

The American Psychiatric Association (APA) is a leading organization dedicated to advancing the field of psychiatry. It focuses on promoting mental health, supporting psychiatric education, and advocating for the profession. The APA provides resources for psychiatrists, residents, medical students, and the public, aiming to improve the understanding and treatment of mental health conditions. The APA's mission is to promote universal and equitable access to the highest quality care for all people affected by mental disorders, including substance use disorders, and to advance psychiatric education and research.

Hylid Diagnostics develops home-based chronic disease monitoring solutions, focusing on simplified, rapid blood testing, digital data integration, and remote care for conditions such as chronic kidney disease and heart failure. Its technology delivers lab-accurate results from finger-prick samples within minutes and integrates these results into cloud-connected platforms for patient and caregiver engagement. The company aims to reduce the costs and poor outcomes associated with chronic kidney and heart failure by enabling at-home testing and AI-guided remote intervention.

Founded by Thomas Jefferson in 1819, the University of Virginia is a prestigious public university that emphasizes the advancement of human knowledge, education of leaders, and cultivation of an informed citizenry. It is recognized for its commitment to academic excellence, vibrant student life, and a strong alumni network, making it one of the top public universities in the United States.

The University of Missouri is dedicated to advancing research, innovation, and impact through a comprehensive support system for faculty, students, and staff. It aims to foster collaboration, enhance economic development, and promote entrepreneurship, while ensuring compliance with research regulations and ethical standards. The university also emphasizes the importance of interdisciplinary partnerships and provides resources to support veteran entrepreneurs through programs like the Entrepreneurship Bootcamp for Veterans.

Prolific Machines is pioneering the use of optogenetics and AI-driven bioprocess optimization to revolutionize biomanufacturing. Their mission is to illuminate biology’s limitless potential for a healthier tomorrow by enabling the production of next-generation therapeutics and broadening patient access to life-altering medicines. Founded in 2020, the company has developed a unique Photomolecular™ platform that uses light to precisely control cellular functions, boosting yields, improving quality, and enabling the manufacture of complex biotherapeutics. With a focus on strategic partnerships, Prolific Machines collaborates with innovators in biopharma and advanced nutrition, offering flexible, scalable solutions and in-house cell line development up to 200-liter pilot scale. The company is recognized for its commitment to safety, innovation, and a collaborative, diverse team culture.

Mistral Inc. is a U.S.-based, woman-owned small business providing advanced defense, public safety, and security technology solutions for over 30 years. The company specializes in manufacturing, integrating, and delivering high-readiness systems for military, law enforcement, and government customers, leveraging extensive experience in metal fabrication, assembly, kitting, electronics, and R&D. Solutions address explosive containment, situational awareness, survivability, UAV and counter-UAV operations, and field detection challenges for North American and global clients.

Legionarius specializes in developing smart garments designed for real-time detection of wounds and hemorrhaging in high-risk environments, such as combat, action sports, and industrial operations. Their mission is to revolutionize personal safety with sensor-integrated solutions that provide immediate injury alerts and remote triage capability.

ADS, Inc. (Atlantic Diving Supply) is a leading value-added logistics and supply chain solutions provider serving all branches of the U.S. Military, federal, state and local government organizations, law enforcement agencies, first responders, partner nations, and the defense industry. Founded in 1997 in Virginia Beach, VA, ADS has grown into a Top 50 Department of Defense Contractor, recognized for its commitment to legendary customer service, broad procurement options, and innovative product and service offerings. The company is deeply rooted in its community, supporting military families, veterans, and first responders through scholarships, corporate giving, and ongoing service. ADS upholds the highest standards of business ethics, compliance, and quality, as demonstrated by its AS9100D, ISO 9001:2015, and ISO 14001:2015 certifications.

NeuroIntact is a medical device company based in Baltimore, Maryland, focused on developing targeted temperature management (TTM) therapies to preserve neurological function in critical care settings, including stroke, traumatic brain injury, and cardiac arrest. The company specializes in intranasal delivery of TTM, aiming to optimize brain temperature while minimizing systemic effects and side effects seen with whole-body cooling. Backed by recent funding and industry partnerships, NeuroIntact is advancing its devices through clinical evaluation and commercialization, with a focus on improving patient outcomes and care for both military and civilian populations.

The University of Massachusetts Lowell (UML) is dedicated to providing a comprehensive educational experience that prepares students for success in their careers and lives. With over 200 degree programs and a commitment to research and community engagement, UML fosters a vibrant learning environment for its diverse student body.

Leidos is a leading systems integrator in science, technology, and engineering, dedicated to solving some of the world's toughest challenges. The company emphasizes a commitment to integrity, diversity, and sustainability while delivering innovative solutions across various sectors including defense, healthcare, and energy.

Dandelion Medical Devices (DMD) is dedicated to revolutionizing pulse detection by delivering rapid, objective, and accurate weak pulse detection. Their mission is to eliminate guesswork in critical care by replacing the standard of care, manual palpation—which is only 54% accurate—by providing innovative, patent-protected devices that empower clinicians with real-time, actionable data. DMD's vision is to set a new standard in weak pulse detection, ensuring that every patient receives the highest level of care when it matters most. The company brings together a multidisciplinary team with deep expertise in medicine, engineering, law, and manufacturing, and is committed to advancing healthcare through technology and clinical precision.

Concept Plus is a certified small business specializing in providing innovative technology solutions and services to the federal government. With a focus on cloud computing, data analytics, artificial intelligence, and modernizing mission-critical enterprise systems, Concept Plus aims to maximize client results through strategic IT alignment and deep technical expertise.

Vivonics, Inc. is dedicated to creating innovative solutions to address unmet medical and wellness needs, focusing on mobile physiological monitoring, advanced diagnostics, non-invasive interventions, and clinical decision support technologies. Founded in 2012, the company collaborates with a network of clinical and academic partners to enhance human health and performance in various challenging environments.

The Institute for Trauma Recovery is a multidisciplinary team at the University of North Carolina at Chapel Hill focused on advancing the understanding of trauma recovery processes and developing interventions to promote rapid recovery and prevent chronic symptoms. The institute values collaboration among faculty and staff to improve care for individuals who have experienced trauma.

RTI International is an independent nonprofit research institute dedicated to improving the human condition. With a vision to address the world's most critical problems through science-based solutions, RTI integrates expertise across social and laboratory sciences, engineering, and international development to deliver reliable data, thorough analysis, and innovative methods that inform public policy and practice.

Kendall Square Sciences is dedicated to designing, developing, and commercializing personal metabolic sensors. Their technology is based on a novel metabolic fuel model and low-cost breath sensor, which measures, tracks, and enhances metabolism. The company aims to provide accurate, affordable, and accessible metabolic measurements to optimize metabolic health with real-time personalized insights.

The University of Nebraska Medical Center (UNMC) is dedicated to transforming lives through premier educational programs, innovative research, and extraordinary patient care. Founded in 1869, UNMC is a leader in health sciences education and research, serving as a vital resource for Nebraska and beyond.

The University of Georgia (UGA) is dedicated to facilitating instruction, scholarly and creative activity, and research collaborations across disciplines. UGA is a leader in research-based products and innovation, significantly impacting the state of Georgia and beyond through its extensive research initiatives and academic programs.

PyrAmes is a digital health company focused on transforming healthcare delivery through advanced sensor measurement. The company is developing a proprietary platform for continuous, accurate, wireless, and non-invasive blood pressure monitoring for patients of all ages, from newborns to seniors. PyrAmes aims to make blood pressure monitoring easy, low-cost, unobtrusive, and painless, ultimately improving patient outcomes.

Southern Research (SR) is a nonprofit preclinical contract research institute that has been bridging basic science and commercial solutions for over 80 years. From pioneering chemotherapy research in collaboration with Memorial Sloan Kettering to generating millions of data points in the global fight against COVID-19, SR has consistently been at the forefront of scientific innovation. Our team of experts excels in transforming cutting-edge science into tangible societal benefits, utilizing comprehensive drug discovery and development capabilities to drive innovation and advance life-saving medical breakthroughs. SR collaborates with over 100 industrial partners, the federal government, and numerous academic institutions to advance the development of life-saving medicines.

BelleTorus Corporation, known as Belle.ai, is dedicated to enhancing global skin healthcare access through innovative AI technology. Their mission is to assist healthcare professionals in addressing the unmet demands for dermatology by providing tools that analyze over 1,600 skin conditions from smartphone images. Belle.ai's technology supports healthcare providers with objective scoring for immune-mediated skin disorders and is utilized by researchers and pharmaceutical companies worldwide to study and evaluate skin health treatments.

Phare Bio is a social venture dedicated to addressing the urgent global threat of antibiotic resistance through innovative AI and deep learning technologies. The company aims to revolutionize antibiotic discovery and development, ensuring that new antibiotics reach those in greatest need.

Turner Imaging Systems is dedicated to revolutionizing medical imaging with its innovative SMART-C® mini C-arm. This portable, battery-operated device provides real-time fluoroscopic imaging, enhancing diagnostic capabilities in various medical fields, including sports medicine, emergency care, and veterinary medicine. The SMART-C® is designed for efficiency, portability, and ease of use, allowing healthcare professionals to perform imaging directly at the point of care, improving patient outcomes and workflow efficiency.

MassBiologics, part of UMass Chan Medical School, is the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States. With over 100 years of experience, it is dedicated to improving public health through the research, development, and production of biologic products, including vaccines and monoclonal antibodies.

TDA Research, Inc. is dedicated to addressing complex real-world problems through innovative research and development in chemical processes, materials, and hardware. With a focus on agility and collaboration, TDA partners with clients in defense, aerospace, energy, and chemical industries to deliver cutting-edge solutions and technologies.

Ceres Nanosciences, Inc. is a privately held company based in Northern Virginia, specializing in the development and commercialization of Nanotrap® hydrogel particle technology. Their mission is to deliver innovative products powered by Nanotrap Technology to address life science needs and provide better patient outcomes. Ceres' products enable the capture, concentration, and preservation of low-abundance analytes from diverse biological and environmental samples, supporting applications in diagnostics, research, and public health surveillance. The company is ISO 9001:2015 certified and collaborates with leading research institutions, public health agencies, and industry partners to advance global health security and biosecurity. Ceres has established a national network of Wastewater-based Epidemiology Centers of Excellence and has received significant funding from the NIH RADx initiative and other organizations to expand its impact in underserved communities. Their technology is widely adopted for wastewater-based epidemiology, proteomics, and nucleic acid analysis, with a strong focus on supporting public health monitoring, early detection of infectious diseases, and environmental bio-surveillance.

BrightFocus Foundation is a leading nonprofit organization dedicated to funding innovative scientific research and providing expert information to defeat Alzheimer’s disease, macular degeneration, and glaucoma. With a mission to envision a world where everyone can age free from diseases of mind and sight, BrightFocus invests in groundbreaking research, supports the next generation of scientists, and empowers individuals and families with trusted resources. Over its 50-year history, the foundation has awarded nearly $300 million in research grants to more than 6,000 scientists worldwide, catalyzing life-changing breakthroughs and advancing public education on brain and vision health. The foundation's impact is evident in major scientific milestones, such as the first successful cell transplantation for glaucoma, FDA "Breakthrough Therapy" designations, and the development of new diagnostic and therapeutic approaches for neurodegenerative and vision diseases.

NeuroSentry focuses on developing technology-driven solutions for real-time in-hospital stroke detection, addressing a critical clinical gap in perioperative and hospitalized patient care. Their work leverages quantitative EEG methods to enable rapid recognition and intervention for brain injury with the goal of improving outcomes following high-risk surgical procedures.

Metron Adaptive develops AI-driven operational intelligence platforms for organizations operating in high-complexity environments, including defense, logistics, healthcare, and enterprise sectors. The company focuses on using AI-powered analytics and no-code interfaces to unify siloed data and enable real-time, constraint-aware decision-making while ensuring rapid deployment and regulatory compliance.

Design Interactive is a digital transformation company founded in 1998, dedicated to enhancing and optimizing performance through innovative technology solutions. With a focus on software research, development, and cutting-edge UI/UX design, the company aims to exceed expectations and empower organizations with advanced digital tools.

The Medical University of South Carolina (MUSC) is South Carolina’s premier biomedical research institution, dedicated to advancing health through innovative research, education, and clinical care. With over $300 million in research funding and a commitment to addressing pressing health challenges, MUSC fosters collaboration among faculty, staff, and community partners to translate scientific discoveries into impactful health solutions. The South Carolina Clinical & Translational Research Institute (SCTR) at MUSC supports innovative research across the translational spectrum, from basic science to population health, including patient-centered and community-engaged research.

Berkeley FIT is dedicated to fostering innovation through technology, specializing in AI, software engineering, and digital product design. The company partners with both industry leaders and startups to solve complex challenges, leveraging expertise in modern software development, cloud platforms, AI & machine learning, and user-centered UX/UI design. Their mission is to bridge the gap between current needs and future possibilities by delivering technology-driven solutions with real-world impact.

Reinvent Health LLC is a U.S.-based medtech company focused on early-stage R&D of scalable, clinically impactful solutions that improve patient care, streamline clinician workflows, and enhance long-term outcomes. At the intersection of clinical insight, engineering design, and translational science, Reinvent Health rapidly prototypes and tests novel technologies to address unmet needs. The company specializes in platform-oriented innovation, technology transfer, and commercial translation through licensing, spinouts, and strategic partnerships. As part of the Tettron Holdings portfolio, Reinvent Health emphasizes device-agnostic, software-driven systems with real-world usability across both hospital and field environments.

Simpli-Fi Automation, Inc. is dedicated to advancing healthcare through connected technologies that enhance the availability and effectiveness of quality care. With a team boasting over 290 years of combined expertise in software engineering, remote patient monitoring, device engineering, infectious disease control, and advanced manufacturing, Simpli-Fi delivers innovative SaaS and IoT solutions. The company partners with leading organizations and leverages patented and patent-pending technologies to develop non-invasive diagnostic and monitoring devices, aiming to transform patient care, improve provider efficiency, and enable early disease detection.

Lumeto is a leader in healthcare simulation using AI and immersive technologies. Its simulation platform is used for training, skills assessment and workforce development in the healthcare, safety, and defense sectors. Their flagship platform, InvolveXR, leverages AI to deliver scalable, customizable, and competency-mapped simulations accessible from anywhere. Lumeto's mission is to revolutionize healthcare and workforce preparedness by providing realistic, data-driven, and engaging learning experiences that enhance decision-making, communication, and patient safety. The company partners with leading academic institutions, healthcare organizations, and technology providers globally, and is recognized for its evidence-based, adaptable, and inclusive approach to training the next generation of first responders. Lumeto is at the forefront of innovation with AI-driven virtual patients, customizable learning modules, and partnerships that extend into remote and space healthcare training. Recent advancements include the launch of industry-first customizable AI non-patient characters, a fully customizable AI-driven conversational system for healthcare simulation in VR, and scalable self-directed learning capabilities. Lumeto's InvolveXR platform is recognized for its flexibility, fidelity, and scalability, supporting both asynchronous and synchronous training, and is validated by research demonstrating significant improvements in clinical training outcomes.

Prosperous Robotics develops advanced digital health and robotics solutions aimed at restoring mobility, independence, and emotional well-being for individuals with mobility challenges. Drawing on global expertise in robotics, AI, and healthcare, the company focuses on digital rehabilitation, intelligent assistive devices, and integrated care platforms. With strategic presence in the US, Europe, and India, Prosperous Robotics collaborates with leading academic, government, and industry partners to scale innovative technologies and transform mobility care.

Vitls is dedicated to transforming patient care through continuous, wireless monitoring technology. Their mission is to provide peace of mind to patients, nurses, and physicians by enabling 24/7 monitoring of vital signs with unobtrusive, wearable medical devices. By pairing their devices with cloud-based data analysis, Vitls empowers healthcare professionals to make quick, informed decisions, improving patient outcomes and reducing delays in care.

Cytonus Therapeutics is pioneering the convergence of artificial intelligence and synthetic biology to revolutionize drug development and delivery. The company challenges the high failure rates of traditional and precision medicines by developing next-generation therapeutics that are both highly effective and safe. Their mission is to create pragmatic shifts in how drugs are designed and administered, focusing on precision, safety, and efficacy to improve patient outcomes.

Digital Infuzion is a CMMI level 3-appraised information technology firm that specializes in innovative computer services, informatics, and enterprise solutions. With a strong focus on healthcare, the company aims to help clients manage, mine, and make sense of data, driving digital transformations across various sectors. The company prides itself on creativity, openness, and growth, fostering a culture that encourages innovative problem-solving and collaboration.

Gel4Med is a commercial-stage company pioneering the use of smart, bioinspired materials to address major challenges in medicine. Founded out of Harvard Innovation Labs, Gel4Med leverages its proprietary Smart Materials Platform™ (SMP™) to develop advanced therapeutics and devices, with a mission to enhance health outcomes and access for all patients. The company is committed to creating novel biomaterials that improve regenerative medicine and surgical solutions, and has achieved significant milestones including FDA clearance for its lead wound care product, G4Derm™ Plus.

Precision Antibody is a leading provider of custom antibody development services, with over 24 years of experience and more than 20,000 successful projects delivered to over 500 organizations worldwide. The company specializes in rapid, high-quality, application-specific monoclonal and polyclonal antibody development, production, and characterization, serving pharmaceutical, biotech, academic, and government clients. Precision Antibody is recognized for its proprietary technologies, award-winning services, and a success rate exceeding 95% in delivering antibodies that perform as intended. Accredited by AAALAC and OLAW, the company is committed to strict quality control, confidentiality, and milestone-based, transparent pricing. Their mission is to enable scientific advancement through innovative, reliable, and tailored antibody solutions.

RIVANNA is dedicated to developing and commercializing innovative imaging-based medical technologies that enhance the precision, safety, and efficiency of spinal needle interventions. Founded in 2010, the company focuses on addressing unmet clinical needs in neuraxial anesthesia and other medical applications, striving to elevate global standards of care through advanced ultrasound imaging technology and clinician assistance software. RIVANNA is also exploring applications of its technology in chronic pain management and musculoskeletal imaging, aiming to provide safer, non-radiation-based alternatives for patients.

MATTER is a collaborative community of healthcare innovators dedicated to advancing care, accelerating innovation, and improving lives. The organization provides a platform for startups, corporations, and investors to connect and collaborate on healthcare solutions. MATTER supports entrepreneurs with resources, mentorship, and a dynamic community to foster innovation in the healthcare sector. Since its inception in 2015, MATTER has worked with over 1,000 healthcare technology ventures and partners with industry-leading companies, health systems, and universities.

Instant Systems specializes in the design and manufacture of single-use sterile systems for cell and gene therapy, regenerative medicine, tissue banking, and related bioprocessing applications. The company offers a wide range of customizable solutions for cell culturing, fluid management, media and waste containment, magnetic cell separation, and sterile filtration, with a focus on maintaining process integrity from production through delivery. Their products support closed-system workflows, scalability, and integration into existing manufacturing and research environments.

Home Base is a national nonprofit organization dedicated to healing the invisible wounds of war for Veterans, Service Members, Military Families, and Families of the Fallen. Founded by Massachusetts General Hospital and the Boston Red Sox, Home Base provides world-class clinical care, wellness, education, and research at no cost to participants, regardless of their era of service, discharge status, or geographical location. The organization operates the first and largest private-sector clinic in the nation devoted to treating post-traumatic stress, traumatic brain injury, and other related issues. Home Base has served over 45,000 individuals across 50 U.S. states, 13 countries, and 5 territories, all at no out-of-pocket cost.

HERO Medical Technologies is dedicated to revolutionizing emergency care through innovative wearable technology and AI-driven analytics. Their mission is to enhance patient monitoring and treatment, particularly in critical situations such as traumatic brain injuries and strokes, ensuring timely and effective medical responses.

Glaive Medical Optics, Inc. develops advanced intraocular lens technologies aimed at restoring vision for individuals affected by macular diseases that cause blindness. The company leverages innovation in ophthalmology and interdisciplinary expertise across optics, engineering, and materials science to deliver transformative therapies enabling patients to regain sight.

SynVivo is a pioneering provider of cell-based microfluidic organ-on-chip platforms, delivering biologically realistic microenvironments for real-time study of cellular behavior, drug delivery, and drug discovery. Their proprietary technology bridges microfluidics and bioengineering, enabling advanced research in life sciences, disease modeling, and personalized medicine. SynVivo's chips support microvascular networks that closely mimic in vivo tissue conditions, validated by scientific research to more accurately reflect human biology than conventional culture methods. The platform is especially impactful for personalized cancer therapy, allowing patient-derived cells to be used for drug efficacy testing in a simulated tumor environment. SynVivo also distributes a wide range of high-quality primary cells and cell lines from various species, supporting research in immunology, cardiovascular, and cancer biology.

Surgical Magic develops real-time, AI-driven prediction systems for stroke risk. Using advanced algorithms and standard monitoring inputs, the technology predicts stroke events potentially minutes before they occur, enabling physicians to take preventative actions and improve patient outcomes. The company emphasizes validation and regulatory compliance through multi-site clinical trials and aims to advance operating rooms from reactive to predictive care.

Crainio is a UK-based medical technology company focused on revolutionizing the measurement of intracranial pressure (ICP) through a non-invasive, real-time, and affordable device. Their mission is to improve the diagnosis and treatment of traumatic brain injury (TBI) by providing clinicians with continuous ICP monitoring without the need for invasive procedures. Using low-power infrared light and advanced machine learning algorithms, Crainio's technology aims to make ICP measurement accessible, safe, and effective for a wide range of healthcare settings.

SoarTech is an industry leader in the application of innovative, context-informed AI solutions for Department of Defense (DoD) research and development problems. The company focuses on developing intelligent software that reasons like humans, automating complex tasks, simplifying human-machine interactions, and modeling human behaviors. SoarTech emphasizes a human-centered approach to AI, aiming to enhance human capabilities rather than replace them, and is committed to transparency and explainability in AI systems.

iXpressGenes is a biotechnology company dedicated to transforming trauma care through innovative, science-driven solutions. Their mission is to bridge the gap between mental and physical health by detecting and addressing trauma-induced conditions before symptoms emerge. Leveraging advanced RNA biomarker technology, iXpressGenes empowers healthcare providers to deliver proactive, data-driven care that prevents long-term suffering and improves patient outcomes. The company is committed to early detection, prevention, and the development of tools that legitimize the biological realities of trauma, ultimately redefining the future of trauma care.

JFD-PK Medical LLC is a research and development company specializing in critical care solutions. Founded by a board-certified pulmonologist, the company focuses on developing innovative chest drainage systems, advanced guidewire and tunneling devices, and pleural drainage catheters to improve outcomes for critically ill patients. Emphasizing innovation and clinician collaboration, it aims to develop and provide innovative, effective, and safe tools for hospital and outpatient clinical environments.

ParaNano Wound Care, LLC is a pre-clinical MedTech company based in Oklahoma City, founded in 2018. The company is dedicated to developing and commercializing advanced wound care solutions, most notably the Bio-Z™ Smart Bandage. ParaNano holds exclusive, worldwide patent rights to foundational nanofiber and biosensor technologies licensed from the University of Central Oklahoma and the University of Manitoba. Their mission is to address the critical gap in wound care by providing real-time, continuous infection detection, empowering both clinicians and patients to intervene early and improve outcomes. ParaNano is recognized for its innovation, strategic partnerships, and commitment to health equity, and is a member of the prestigious Blue Knight program by Johnson & Johnson Innovation and BARDA.

Reliable Systems Engineering, LLC is a consulting firm specializing in systems engineering for the medical device industry. The company supports clients—particularly startups, contract developers, OEMs, and CMOs—through expertise in system architecture, requirements development, risk management, verification, and cross-functional coordination. Its mission is to bring clarity, structure, and guidance to complex device development, ensuring regulatory compliance and efficient progress through disciplined engineering practices, all rooted in recognized industry standards and decades of experience.

Vielight Inc. designs, develops, and manufactures home-use photobiomodulation (PBM) devices for brain health, systemic wellness, and clinical research. The company specializes in non-invasive transcranial and intranasal light therapy systems, including solutions for neural and systemic applications. Their technology is ISO 13485:2016 and MDSAP certified, utilized in over 35 clinical trials, and supported by a significant patent portfolio. Functional outcomes studied include cognitive enhancement, neurological conditions, immune support, brain-body connectivity, and mental well-being. Vielight offers products for professional, research, and consumer use worldwide, and collaborates with leading research institutions.

At Vistendo, we are dedicated to helping athletes stay healthy and perform at their best. We create accessible technology for early health detection, simplifying the process of making health-related decisions for athletes, parents, and coaches.

Vascular BioSciences is a biopharmaceutical and medical device company focused on developing targeted therapeutics, minimally invasive interventional devices, and advanced molecular diagnostics for cardiovascular, pulmonary, and inflammatory diseases. The company leverages targeted peptide drug delivery, endovascular tissue sampling, molecular profiling, and bioinformatics to advance personalized medicine for difficult-to-treat diseases. Its operations span California and North Carolina with expertise in biologics, device engineering, and translational research.

Adaptyx Biosciences develops a wearable platform that turns laboratory-grade biochemical assays into continuous molecular data streams. The company enables minimally invasive, real-time monitoring of diverse biomarkers through programmable molecular sensors combined with advanced electronics and AI-driven analytics. The goal is to provide actionable, continuous health insights for clinicians, facilitating proactive, personalized, and always-on healthcare. The technology is designed for versatility across high-impact use cases such as heart failure management, chronic kidney disease, hormone dysregulation, hospital care and precision drug monitoring. The platform is based on a decade of academic innovation, integrating high-throughput molecular engineering, data-driven design, and robust clinical-grade performance.

CureLab Veterinary is a biotechnology company focused on the development of gene-based therapies targeting cancer and chronic inflammatory diseases in companion animals, such as dogs, cats, and horses. Utilizing advances in comparative medicine and translational immunology, the company applies a plasmid-based platform to stimulate anti-cancer immune responses, modulate tumor microenvironments, and mitigate chronic inflammation. Clinical research leverages academic partnerships and a robust intellectual property portfolio, pursuing efficient regulatory approval pathways in major markets, including the US and Europe. Recent studies suggest broader applications in pain management and cross-species translational potential.

Tria Federal is a premier provider of digital services and technology solutions for the federal government, with a mission to support the health, safety, and operational excellence of veterans, service members, and civilians. Formed through the integration of several legacy companies and the acquisition of Softrams in 2024, Tria delivers end-to-end solutions that modernize, streamline, and transform government systems. The company is recognized for its values-driven culture, commitment to diversity and inclusion, and impactful community engagement. With nearly 1,000 employees across more than 40 states, Tria leverages deep expertise in IT, advisory services, and digital transformation to power possible for its government partners.

LMI is a premier provider of commercial-grade technology and consulting solutions for government agencies, accelerating mission success through innovation, advanced analytics, and digital transformation. With a focus on AI-enabled delivery, rapid platform engineering, and mission operations, LMI leverages low-code/no-code tools, secure modular platforms, and deep federal expertise to solve complex challenges at commercial speed. The company is recognized for its commitment to research, strategic partnerships, and workforce development, empowering government missions ahead of need and ensuring adaptability, efficiency, and future-proof outcomes. LMI's leadership and experts drive impact across defense, intelligence, health, and civilian markets, supported by a culture of innovation and collaboration. LMI's internal R&D studio, LMI Forge, and its team of subject matter experts, further reinforce its position as a leader in mission-focused technology and agile transformation.

Vira Regen Inc. is at the forefront of biotech innovation, focusing on regenerative medicine to address the root causes of diseases and injuries. The company is pioneering the development of novel, gene-specific electroceuticals that stimulate the body's bioelectric network and genetic code, promoting accelerated healing through the body's natural self-repair processes.

TISTA Science and Technology Corporation delivers technology, analytics, and digital transformation for federal agencies, with emphasis on healthcare, supply chain optimization, fraud prevention, and IT modernization. The company integrates artificial intelligence, cybersecurity, cloud, and data engineering expertise to modernize mission-critical systems, enhance operational efficiency, and improve public service outcomes. TISTA is recognized for its application of human-centered design, agile methodologies, measurable impact, and commitment to serving veterans and addressing federal challenges.

Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.

Lunai Bioworks Inc. is an AI-powered company at the intersection of drug discovery, diagnostics, and biodefense. The company integrates generative AI, proprietary neurotoxicity and chemical datasets, multi-omics, and high-throughput in vivo models to identify and validate therapeutic targets, biomarkers, and to safeguard against dual-use biosecurity risks. Lunai Bioworks partners with academia, industry, and government to advance safe and responsible AI-enabled biomedical innovation, spanning oncology, neurology, precision medicine, and countermeasure development for chemical and biological threats.

Applied Research Associates, Inc. (ARA) is a globally recognized scientific research and engineering company dedicated to solving critical national problems to improve safety, security, and quality of life. Founded in 1979, ARA is 100% employee-owned and offers innovative technologies and solutions across various sectors, including national security, infrastructure, health solutions, and energy & environment. The company is committed to delivering mission-critical solutions that exceed expectations and lead to new possibilities.

General Graphene Corporation is a pioneering advanced materials company specializing in the industrial-scale production of chemical vapor deposition (CVD) graphene and carbon materials. Headquartered in Knoxville, Tennessee, the company leverages proprietary, patented roll-to-roll CVD technology to deliver high-quality, reproducible, and affordable graphene and carbon-based materials at mass volumes. Their mission is to make graphene scalable and accessible for real-world applications, enabling innovation across industries such as electronics, energy storage, life sciences, and more. With a focus on overcoming the traditional limitations of CVD graphene manufacturing, General Graphene supports both research and commercial partners in transitioning graphene from laboratory research to industrial adoption, driving the next wave of material science transformation.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

DANE Health, Inc. created an Agentic Medical AI assistant, initially concentrating on neurology and triage to revolutionize care pathways. The company provides individuals and healthcare professionals with practical insights, tailored support, and professional reports, all while ensuring privacy and security. Our AI agent engages in lifelike conversations to tackle complex management or recovery challenges, while monitoring progress over time. DANE Health aims to supply clinicians with clear data to improve patient care and aid in better recovery.

Zymo Research is a global biotechnology company specializing in innovative products and services for sample collection, nucleic acid purification, microbiomics, epigenetics, and next-generation sequencing (NGS). With over 30 years of experience, Zymo Research is recognized for simplifying complex scientific workflows and providing reliable solutions for life science research, clinical diagnostics, and molecular biology applications. The company offers a comprehensive portfolio of kits, standards, and services designed to ensure accuracy, reproducibility, and efficiency in molecular analyses, supporting researchers worldwide.

TecTraum Inc. is pioneering the advancement of concussion therapy with the development of Pro2cool®, the world’s first FDA-designated Breakthrough Device for post-concussion cooling therapy. The company’s mission is to provide a safe, effective, and easy-to-use medical device that can be deployed in various settings to reduce the signs and symptoms of concussion, particularly in athletes. TecTraum emphasizes science before sales, conducting extensive clinical trials to validate the safety and efficacy of its technology. Our vision is to revolutionize concussion treatment and improve patient outcomes. Pro2cool® works by using selective localized external cooling of the head and neck. The technology leverages hypothermic therapy, or cold therapy, in the form of a precisely controlled thermoelectric cooling device and garment applied to the head and neck. Once the pro2cool® is in place, the chiller assembly reduces the temperature of a coolant mixture in the device to 6°C and circulates it through the cooling garment to create precision conductive heat transfer from the head and neck. The physiologic neuroprotective benefit from cooling the injured region occurs at the cellular level. By interrupting the body’s naturally occurring localized inflammatory response with the introduction of cold therapy, the cellular- based metabolic cascade is dampened, thereby minimizing the ensuing damage caused by the body in response to injury. Pro2cool® imparts a proven significant clinical difference through just two treatments at 6°C administered for 30 minutes each, separated by 72 hours from the time of diagnosis. Extensive data derived from a large pivotal clinical trial supports the efficacy of the device. The multisite trial, completed in 2022, was designed to enroll patients between the ages of 12 and 21. It is the first and only concussion treatment study of this population. Four leading pediatric medical centers – three in Ohio and one in Michigan – served as investigational sites: Akron Children’s Hospital, Cincinnati Children’s Hospital Medical Center, Dayton Children’s Hospital, and the University of Michigan’s C.S. Mott Children’s Hospital. In addition to the Breakthrough Device Designation, Pro2cool® has been studied in the largest known clinical trial for concussion therapy; has been issued a first ever Category III CPT reimbursement code by the American Medical Association; and, TecTraum has completed Quality System audits, and received certification as an FDA 13485 registered medical device manufacturer. The company is awaiting FDA clearance under the De Novo regulatory approval pathway. TecTraum has begun production and is looking to partner with the Department of Defense as well as MTEC members to demonstrate the unique and important capabilities of Pro2cool® in support of our Nation’s Warfighters.

Since 2002, Bluehalo Labs has established itself as a key federal contractor capable of delivering sophisticated technological products and engineering services across multiple domains. Based in Albuquerque, New Mexico, the company provides a diverse range of engineering, research and development, and technological services, with a strong focus on areas including space superiority, directed energy, missile defense, C4ISR, cyber/intelligence, and advanced sensor systems. Through its federal contract awards, Bluehalo Labs has provided an extensive array of goods and services to various agencies, including the Department of Defense, Air Force, Navy, Army, and civilian agencies like Customs and Border Protection and the Federal Railroad Administration. The company's contract work spans multiple technological domains, including developing unmanned aerial systems, sensor pod systems, radar equipment, optical communications systems, battle management software, and advanced research initiatives.

Melio is developing a rapid, culture-free bloodborne pathogen testing platform integrating proprietary assays, microfluidics, and machine-learning. The company targets faster and more accurate infectious disease diagnoses, aiming to reduce antimicrobial misuse and address antibiotic resistance. The platform is designed for comprehensive, direct-from-blood detection of a broad spectrum of pathogens, with a focus on real-time adaptability to new and emerging threats. Melio's system is in development and not yet commercialized.

TechConnect is dedicated to catalyzing innovation for positive change by connecting technologists, entrepreneurs, government leaders, and industry stakeholders. The organization facilitates partnerships and collaboration through events, challenges, and innovation programs, aiming to address critical challenges across various sectors including smart cities, advanced manufacturing, and space technology.

Biophoundry specializes in advancing scalable engineered phage-based solutions for therapeutics, diagnostics, and bio-molecular engineering. It is shifting the paradigm from phage discovery to phage design. Its team leverages expertise in synthetic biology, machine learning, and data science to accelerate the development of precision antibiotics and address critical healthcare challenges such as antimicrobial resistance.

Northeastern University is a global research university founded in 1898, renowned for its experiential learning model, high-impact research, and deep partnerships. The university emphasizes innovative teaching and research that engage students, faculty, and alumni in solving real-world problems, fostering a dynamic and inclusive community across its 13 campuses worldwide.

Rajant Corporation is a pioneer in Kinetic Mesh® technology, providing mission-critical wireless networks that ensure continuous connectivity in dynamic environments. Their solutions are designed for various industries, including defense, mining, healthcare, logistics, and public safety, enabling real-time data communication and enhancing operational efficiency. Rajant's commitment to innovation and adaptability positions it as a leader in the wireless communication landscape. Founded in 2001, Rajant has grown to serve over 75 countries, establishing a strong international presence and a reputation for delivering scalable and adaptable wireless solutions.

The Institute for Human & Machine Cognition (IHMC) is a non-profit research institute within the Florida University System focused on advancing human capabilities through interdisciplinary research. IHMC develops technologies and systems in artificial intelligence, robotics, human-machine teaming, cognitive systems, distributed computing, human performance monitoring, and cyber-physical security, with major collaborations in defense, healthcare, aerospace, and education. The institute is internationally recognized for pioneering work in resilience, cognition, natural language processing, multiagent systems, human-centered design, and operational excellence. IHMC also partners in academic programs, such as the state’s first Ph.D. in Intelligent Systems and Robotics, to develop expertise for high-demand technology sectors.

Rebel Medicine is a science-led pharmaceutical company dedicated to revolutionizing acute pain management by developing innovative, non-opioid solutions. Their mission is to create impactful products that improve patient outcomes and reduce healthcare costs. By leveraging novel drug delivery technologies, Rebel Medicine aims to provide effective pain management solutions that eliminate the need for opioids, thus addressing a significant unmet medical need in acute and postoperative pain management.

The University at Buffalo is a leading public research university and flagship of the SUNY System, recognized for its innovative research and commitment to societal impact. It aims to transform scientific and technological breakthroughs into global impact, addressing complex challenges through interdisciplinary collaboration.

Ancilla Technologies and Services, Inc. is a Service-disabled Veteran-owned Small Business (SDVOSB) founded on Veterans Day in 2015. The company is dedicated to providing superior services by integrating proven business and management practices with teamwork to maximize outcomes for their clients. Ancilla focuses on delivering client-centered services by attracting and retaining team members through competitive salaries, comprehensive benefits, and a rewarding environment. Their mission is to help clients identify and solve their toughest challenges, making a difference and making it better for all those they serve.

BDR Solutions, LLC is a Service-Disabled Veteran-Owned Small Business (SDVOSB) founded in 2016 by U.S. Navy Veteran Bob Rowe. The company is dedicated to improving healthcare outcomes for Veterans, service members, and their families by leveraging innovative technology and compassionate care. BDR specializes in modernizing government systems in health, social services, and disaster relief, with a mission to deliver impactful, tech-driven solutions that exceed mission objectives for diverse government clients. Their vision is to anchor the future with tech-driven health for the nation’s heroes, ensuring the highest quality support across all sectors.

Principle Diagnostics is a state-of-the-art clinical and anatomic pathology laboratory founded in 2015, specializing in toxicology, molecular, and genetic testing. Licensed in over 40 states and led by an executive team with over 50 years of cumulative experience, Principle Diagnostics is committed to operational efficiency, adaptive innovation, and personalized service. The company serves a diverse clientele—including individuals, medical facilities, and research organizations—across sectors such as pain management, substance abuse, podiatry, urology, long-term care, memory care, and assisted living. Principle Diagnostics aims to be a leader in diagnostic services by continuously expanding its comprehensive test menu and upholding values of integrity, service, excellence, and innovation. The company is recognized for its strong focus on compliance, financial integrity, and the integration of advanced therapeutic management and antibiotic stewardship programs. Principle Diagnostics is also celebrated for its commitment to ethical principles, teamwork, and inspired people, striving to set an example in the industry for trust, credibility, and patient-focused outcomes. In 2024, Principle Diagnostics celebrated a decade of pioneering advancements in pharmacogenomic (PGx) testing, further cementing its role as an innovation leader in personalized medicine.

ZOLL Medical Corporation, a subsidiary of Asahi Kasei, is a global leader in developing and marketing medical devices and software solutions aimed at advancing emergency care and improving patient outcomes. Founded in 1980 and named after Dr. Paul Zoll, the company is renowned for its innovative technologies in defibrillation, cardiac monitoring, and other critical care solutions. ZOLL is committed to enhancing clinical and operational efficiencies, supporting healthcare professionals and lay rescuers worldwide in addressing serious cardiopulmonary and respiratory conditions.

BioMojo LLC is a biomedical performance solutions company based in Research Triangle Park, North Carolina. It creates integrated software and hardware solutions to improve human performance, decision-making, knowledge management, resilience, and mission-critical task execution for complex, high-consequence environments. The company leverages advancements in various technologies to enhance the speed, safety, and efficiency of human operators in high-stakes situations.

Seegnal presents a paradigm shift in combating Adverse Drug Reactions and their impacts, including health consequences, economic repercussions in re-admissions and re-visits, and doctors' fatigue, as well as streamlining the prescription process at the point of care, by moving the industry from DDI standard (Drug to Drug Interaction) to a new Patient at the Core standard. The platform integrates seamlessly with any Electronic Medical Records (EMR) system to offer personalized medication recommendations, including Precision Medication, in real-time with an unparalleled accuracy rate of 98%. Seegnal’s Digital Co-Pilot presents the future of prescribing medications at the point of care.

Vista LifeSciences is dedicated to improving health and innovating solutions across various environments, including urban, rural, and remote areas. The company specializes in cognitive and behavioral health assessments through its Automated Neuropsychological Assessment Metrics (ANAM) and offers mobile software solutions for patient management and population health.

UC San Francisco is a leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. With a commitment to public service, UCSF aims to innovate health care approaches for vulnerable populations and train the next generation of health professionals.

Fulmer Instruments is a medical device company based in Alabama developing handheld, cordless surgical instruments focused on replacing outdated, corded operating room technology. With a core commitment to human-centered design, engineering, and advanced manufacturing, the company aims to provide tools that empower healthcare professionals with intuitive, reliable, and precise devices. Their innovation seeks to address critical clinical needs by enabling surgical precision and improving safety and workflow in challenging environments, both in hospitals and austere field settings. Fulmer Instruments leverages Alabama's engineering and manufacturing ecosystem and is in pre-clinical development, pursuing regulatory clearance.

COMPANY: Founded in 2012, Legacy Innovation Inc is a lean, nimble, technology & product development company inventing technologies in pressure, temperature, and flow (complex fluid dynamics) with corporate headquarters in Boise Idaho and an R&D office at VelocityTX in San Antonio. TEAM: Talented and dedicated entrepreneurs, inventors, engineers, and project managers supported by a diverse collaborative network of subject matter experts and teaming partners across multiple disciplines and market sectors. Teaming Partners tend to have their own IP and know-how to complement Legacy’s innovation. PRIMARY AREAS OF EXPERTISE/COMPETENCIES: Our journey began in the draught beer industry creating award-winning thermoelectric cooling and pressure regulation technologies. During the pandemic, we pivoted those technologies to develop simple, portable, medical device platforms in “bleeding & breathing” specifically designed for prehospital care by EMS / first responders in civilian & military applications, especially effective in austere and remote environments. FULL-SERVICE CAPABILITIES: End-to-end services include concept development, design, rapid prototyping, and manufacturing that leverages subject matter experts and teaming partner organizations for customer discovery, R&D, implementation, and commercialization. Primary R&D activities occur in-house, or in-house at teaming partner facilities, to expedite development. MISSION: Create and deliver targeted solutions in pressure, temperature & flow that disrupt the status quo to create new paradigms and industry standards that give our clients massive competitive advantage with little to no competition. VALUES: 1) Customer Discovery extends far beyond initial investigation to permeate everything we say and do. This delivers maximum value to clients and perpetuates our core technologies. 2) Win/Win Approach ensures that every individual and organization involved in a Legacy project has a definable win other than money to boost engagement and impact. 3) Simple, Elegant, Intuitive Design streamlines commercialization, optimizes user experience, stymies potential competitors, and fast-tracks alternative uses for our technologies. WHAT MAKES US DIFFERENT: While our technical lane is narrow, applications are infinite across a wide range of market sectors from medical to industrial to entertainment. This fosters efficient growth with the diversity to insulate against downturns in the economy and disruption in any one market sector. Our established technology base, focused patent portfolio, and robust niche know-how demonstrate our proven technical acumen. Our military, government, and commercial contracts validate our capacity to meet rigorous standards and deadlines. Our broad and eclectic network spans multiple disciplines and markets including medical, military, government, industrial, and academic sectors. This arms Legacy with a deep well of unique resources and expertise to draw upon for project success. NOTABLE CLIENTS: Apple, ITW, Marriott, US Air Force - 59th Medical Wing, US Department of Transportation (SBIR Phase I & II), National Institute for Defense Health Cooperation / Uniformed Services University (Henry Jackson Foundation contract)

Gallatin develops advanced AI-powered software to modernize defense logistics, enabling military and allied forces to achieve improved resiliency, adaptability, and decision advantage in supply chain operations. Their mission is to transform logistics from a vulnerability into a strategic asset, providing commanders and logisticians with predictive analytics, automation, and real-time operational insights.

InformedDNA is a leading precision health company dedicated to revolutionizing the application and implementation of genomic insights to enhance patient care and improve outcomes for all. With over 15 years of experience and the largest in-house staff of board-certified genetics specialists in the U.S., InformedDNA combines deep genetics expertise and advanced technology to deliver real-time, evidence-based solutions for optimizing clinical decisions, improving outcomes, and realizing cost savings at scale. The company supports payors, providers, employers, life sciences, and patients with equal access to genomics clinicians, genetic counselors, and tech-driven solutions. InformedDNA is committed to advancing personalized healthcare, health equity, and cost-effective care, shaping the future of precision health through ongoing innovation, education, and a strong focus on integrity and patient privacy.

Brinter is a pioneering US-based MedTech firm focused on revolutionizing tissue engineering through the development of 3D bioprinted biocomposite regenerative implants, known as BioMods™, which aim to restore damaged tissue and replace conventional implants, launching in orthopedics/tendons and ligaments. The company driven by a team of visionary entrepreneurs and leading bioscientists and engineers.

Opticyte is a medical device company dedicated to transforming the standard of care for hemorrhage, sepsis, and other leading causes of organ failure. Their mission is to save lives through early detection and real-time measurement of cellular and blood oxygen levels, providing accurate diagnostics for all skin tones and addressing critical health equity issues. Founded in 2016 as a spinout from the University of Washington, Opticyte is pioneering the first device to measure oxygen inside cells in real time, aiming to reduce organ failure and death associated with hemorrhage, sepsis, and other critical illnesses. The company is recognized for its innovative approach, commitment to health equity, and strong leadership in medical technology.

Caretaker Medical is a digital health company focused on developing advanced hemodynamic monitoring devices. Their flagship product, VitalStream, offers continuous, noninvasive monitoring of vital signs, enabling healthcare professionals to make informed decisions and improve patient outcomes across various care settings, including emergency rooms, operating theaters, and long-term acute care facilities. The company aims to enhance clinical processes and patient safety through innovative wireless technology.

Calla Lily Clinical Care develops patented medical device technologies engineered to improve intravaginal drug delivery for women's health, focusing on clinical needs such as fertility support, pregnancy management, prevention of recurrent miscarriage, and restoration of the vaginal microbiome. Recognized for innovation, the company maintains collaborative partnerships with clinical and academic institutions and secures funding to advance clinical trials and R&D. Their technology is designed for leak prevention, convenience, and dosing confidence, with a strong commitment to sustainability and social impact as a certified B-Corporation.

MaXentric Technologies, founded in 2003, is a leading R&D organization specializing in radio frequency technology and advanced electronics. With over 20 years in the market, MaXentric has developed a robust portfolio of proprietary products and solutions for both commercial and government clients. The company is committed to engineering excellence, innovation, and collaboration, with a highly educated team (over 57% holding advanced degrees) spread across three locations in the US. MaXentric's mission is to deliver high-quality electronics integration, high-end circuitry, and high-speed communication devices, continually pushing the boundaries of next-generation wireless and sensing technologies. The company fosters a diverse, inclusive, and collaborative work culture, offering growth opportunities for employees and interns alike.

NXTech is a translational science company building signal processing and neuromodulation systems to enhance human performance. Our mission is to commercialize breakthroughs in cognitive science and engineering; addressing unmet medical needs, both in-field and at the homefront.

Cook MyoSite, a subsidiary of Cook Group, has been advancing human muscle cell technology since 2002. Operating under ISO 9001:2015-certified quality standards, we specialize in primary human skeletal muscle-derived cells and fibro-adipogenic progenitors sourced from healthy donors and individuals with neuromuscular, metabolic, and rare disorders. Our offerings include custom cell procurement, specialized media formulations, and contract manufacturing services—supporting both academic research and clinical development in regenerative medicine. Beyond research tools, Cook MyoSite is pioneering autologous muscle-derived cell therapies. Our investigational product, iltamiocel, is currently in a Phase III clinical trial for fecal incontinence, demonstrating our commitment to translating cell-based science into real-world solutions. With expertise in GMP manufacturing, analytical testing, and tailored partnerships, we empower collaborators to accelerate innovation in musculoskeletal and neuromuscular health worldwide.

The University of North Carolina at Chapel Hill, the nation’s first public university, is dedicated to teaching, research, and public service. It aims to serve North Carolina, the United States, and the world by fostering a diverse community of students and preparing them to become leaders. With a commitment to excellence, UNC-Chapel Hill invests in knowledge and resources to enhance learning and improve the quality of life for all people in the state. The university is recognized for its innovative teaching, groundbreaking research, and dedication to public service, continuing a legacy that began in 1789.

Oridivus is pioneering the development of the first FDA-approved oral wound healing therapy, with a mission to transform pediatric oral health outcomes. The company addresses critical unmet needs in oral surgery by accelerating healing, reducing pain, and minimizing opioid dependency, especially in young patients. Oridivus leverages advanced biomaterials and immunomodulatory compounds to provide faster, safer, and more effective recovery for procedures such as wisdom tooth extractions, cleft palate repairs, and oral trauma. Their vision is to improve quality of life for children and young adults, break the cycle of opioid dependency, and set new standards in oral wound care.

VitaKey is pioneering a new era in nutrition by applying precision delivery technology to enhance the nutrient density of foods and beverages. Developed at MIT, Langer Lab, and co-founded by Dr. Robert S. Langer, VitaKey's platforms aim to address global health challenges, including diet related diseases such as obesity, heart disease and diabetes. VitaKey technologies ensure the stability and controlled release of nutrients (macronutrients, micronutrients, probiotics, bioactives, etc.) to improve bioavailability and enhance the functionality of foods and beverages. VitaKey creates all natural food and beverage solutions to enhance human performance, boost satiety, and improve the health and wellness of all consumers.

Hemanext is a privately held medical technology company specializing in oxygen-controlled red blood cell processing and storage systems for transfusion medicine. The company develops, manufactures, and commercializes innovative storage solutions that preserve the quality and function of red blood cells by limiting oxygen and carbon dioxide exposure, with the goal of improving transfusion outcomes for patients with chronic and acute conditions. Hemanext's products have received FDA De Novo marketing authorization and CE Mark certification, enabling global distribution. The company is recognized for its focus on scientific evidence, operational compatibility, and strategic partnerships with blood establishments and clinical researchers.

Aiming to minimize radiology error of 30% in healthcare delivery, XENSE 's Meta CT /AI  technology offers accurate standardized real time 3D imaging & 3D physical model for healthcare delivery of critical illnesses with ultralow x-ray radiation,  replacing  traditional CT , fluoroscope, general x ray, densitometer and other medical x modalities and related AI solutions  used in prediction, diagnosis and intervention guidance with one AI powered compact device with higher performances previously not possible.  With initial fundings from NASA and Department of Transportation, based on 30+ years of R & D and effort of two generations of engineers/physicist/molecular biologist from MIT,  Harvard Medical School, Columbia University and Boston University, the first Meta CT / AI aims to  minimize radiology errors, dramatically reduce radiation exposure, significantly lowering costs for the healthcare delivery and minimizing time to diagnosis, intervention & wellness. XENSE has filed 70+ and been granted multiple patents in imaging hardware, algorithms, AI and supporting technologies, though its primary products are currently in development and not yet FDA approved for commercial use.

VitaCyte specializes in the manufacture and supply of GMP Grade purified-defined collagenase and protease enzymes for cell and tissue dissociation. The company is dedicated to supporting researchers, commercial cell suppliers, and institutions involved in cell therapy and transplantation, providing high-quality products that enhance the efficiency and effectiveness of cell isolation processes. VitaCyte is committed to improving the science of cell recovery and has a history of innovative solutions in the field of cell isolation, contributing to significant advancements such as the Edmonton Protocol for islet transplantation. Their products, particularly the purified-defined collagenase, ensure high lot-to-lot consistency and rigorous enzyme characterization, setting a standard in the industry.

Luna Labs is a world-class technology and product development resource for the defense and healthcare industries. Collaborating across our core capabilities in Advanced Materials, Engineered Systems, and Biotechnology, our teams generate solutions for the most demanding environments and customers to save time, save money, and save lives. We partner with universities, government labs, and other world class companies to explore technological feasibility of new ideas, align technologies with customer needs, and generate solutions. Working with a robust global network of manufacturers, suppliers, licensees, and distributors, Luna Labs develops everything from small-scale prototypes up to market-ready products.

Document Storage Systems, Inc. (DSS, Inc.) is a leading health information technology (HIT) software development and systems integration company with over 30 years of experience. DSS delivers innovative, secure, and efficient healthcare technology solutions and services used daily by thousands of clinicians and administrative staff nationwide, across federal, private, and public healthcare sectors. The company is dedicated to improving productivity and healthcare delivery, with a strong focus on digital transformation, interoperability, regulatory compliance, and above all, patient care. DSS is recognized for its deep expertise in modernizing legacy systems, supporting the Department of Veterans Affairs, and delivering solutions that enhance provider performance and patient outcomes. DSS is a member of the Open Source Electronic Health Record Agent (OSEHRA) and a founder of the VistA Extension Hub, fostering open source collaboration in healthcare IT. The company is also known for its rapid nationwide implementations, strategic partnerships, and a legacy of enabling significant cost savings and operational efficiencies for the VA and other healthcare organizations. DSS has been repeatedly recognized in the Healthcare Informatics Top 100 list of leading healthcare IT vendors, reflecting its industry impact and growth.

Minnesota Wire is a privately owned, industry-leading custom wire and cable manufacturer based in St. Paul, Minnesota, with over 50 years of experience. The company specializes in designing, developing, and manufacturing high-performance wire, cable, and interconnect assemblies for mission-critical applications across medical, aerospace, defense, and industrial markets. Renowned for its commitment to innovation, quality, and engineering excellence, Minnesota Wire leverages advanced R&D, vertically integrated manufacturing, and a customer-centric approach to deliver life-saving connections and cutting-edge solutions. The company is AS9100, ISO9001, IPC-620, and MIL-STD certified, and is recognized for its contributions to technological advancement, community impact, and sustainability. Minnesota Wire is now a woman-owned business, marking a new era of growth and inclusivity.

Tunnell Government Services, Inc. is a subsidiary of Tunnell Consulting, Inc., dedicated to providing professional services to government agencies. The company focuses on transforming organizations to achieve sustainable results and fulfill agency missions. With expertise in public health preparedness, biodefense lab support, and scientific project portfolio management, Tunnell Government Services partners with government organizations to address the greatest threats to public health and enhance organizational performance.

Novel Microdevices, Inc. is a woman-owned, woman-led company based in Baltimore, Maryland, specializing in the development of ultra-portable, rapid, point-of-care molecular diagnostic systems. Their mission is to revolutionize infectious disease diagnostics, particularly for women’s health and under-resourced populations, by providing fast, accurate, and affordable testing solutions. Their flagship platform, Novel Dx, is designed to deliver lab-quality results in under 15 minutes, enabling immediate diagnosis and treatment at the point of care. The company is committed to addressing global health challenges, including antibiotic-resistant infections, through innovative technology and strategic partnerships.

Diopter Technologies is a medical device company focused on developing innovative therapeutic solutions for ophthalmic conditions, including drug delivery via advanced contact lenses and dissolvable amniotic membrane biopolymer devices for ocular surface injuries and post-surgical recovery. By integrating sustained drug delivery into wearable platforms, the company enhances warfighter capabilities through improved operational readiness, providing a "set-and-forget" treatment for infections and trauma that eliminates the need for frequent eye drops in high-intensity or austere field environments. For veterans, these technologies offer life-changing regenerative solutions for service-connected ocular trauma and chronic conditions, promoting faster tissue healing and improving patient compliance through convenient, non-surgical alternatives that restore visual acuity and long-term quality of life.

Empatica is dedicated to advancing healthcare through innovative wearable technology and digital biomarkers. Their mission is to provide continuous health monitoring solutions that empower patients and enhance clinical research, particularly in the field of epilepsy monitoring and other health conditions. With a focus on academic studies and clinical trials, Empatica's technology is designed to collect high-quality physiological data and digital biomarkers, facilitating research and improving patient outcomes.

RTM Vital Signs LLC is a Philadelphia-based medical device company focused on transforming healthcare from reactive and hospital-centered to preventive, proactive, evidence-based, and person-centered. Specializing in real-time sensing, monitoring, and analysis of critical health information, RTM Vital Signs targets cardiovascular and respiratory health. The company leverages proprietary, cost-effective monitoring technology, advanced sensors, and AI-driven diagnostic algorithms to provide continuous, real-time health status tracking for both hospital and ambulatory patients. Their mission is to enable better health outcomes, lower costs, and improve patient and staff experiences through innovative wearable devices and continuous monitoring solutions. RTM's patented solutions are designed for seamless integration with smart devices and wearables, supporting timely diagnosis, predictive analytics, and improved telemedicine capabilities. Their technology also addresses key public health challenges such as hypertension, respiratory compromise, and opioid-induced respiratory depression, with applications extending to fitness, industrial safety, and veterinary medicine.

Pressure Medical develops advanced medical devices focused on severe hemorrhage control and trauma care, particularly for military and high-risk civilian environments. The company specializes in smart pneumatic and junctional tourniquets designed for rapid and effective bleeding control in emergency situations, emphasizing ease of use, minimal training requirements, and patient limb preservation. With multiple issued patents and collaborations with government and defense agencies, Pressure Medical aims to enhance combat medical care and improve survival outcomes through innovative biomedical engineering.

Corscience is a German-based medical technology development and manufacturing provider specializing in advanced solutions for defibrillation, patient monitoring, and vital sign acquisition. The company supports OEMs and medtech startups internationally with expertise across R&D, regulatory affairs (including MDR and FDA compliance), quality management, lifecycle management, and technical consulting. Their track record includes the delivery of complex, safety-critical systems and robust integration of electronic, software, and mechanical components in medical devices.

QoreHealth is dedicated to transforming healthcare accessibility through AI-powered, portable diagnostic and telemedicine solutions. Our mission is to enable rapid screening, early detection, and specialist-guided interventions in emergency, remote, and underserved environments. By integrating advanced mobile technology, edge computing, and real-time data, QoreHealth aims to deliver scalable health impact and drive global health equity.

UCLA is a leading public research university located in Los Angeles, California. It is renowned for its commitment to the creation, dissemination, preservation, and application of knowledge for the advancement of global society. With a rich history of academic and athletic excellence, UCLA offers a comprehensive environment that supports both academic and personal growth. The university is dedicated to fostering innovation and making a significant impact on the world through groundbreaking research and transformative practices.

Riptide Bioscience develops engineered peptides derived from host defense peptides found widely in nature. Their focus is on creating peptide-based therapeutics for cancer, inflammatory diseases, and microbial infections, especially those resistant to conventional treatments. The company advances both preclinical and early-stage clinical programs, collaborates with academic partners and government agencies, and holds patents for its engineered peptide design technologies.

CFD Research Corporation specializes in engineering simulations, advanced prototypes, and innovative designs for aerospace, defense, life sciences, materials, energy, and other industries. The company is committed to delivering innovative technologies, services, and products to empower customers for success, transforming the future through innovative technology solutions.

Genomind is a leader in precision medicine for mental health, dedicated to helping healthcare providers and patients make better prescribing decisions by leveraging genetic, lifestyle, and environmental data. Their mission is to personalize mental health treatment and improve outcomes for individuals, providers, and healthcare systems. Genomind supports a wide range of stakeholders, including individuals, providers, long-term care facilities, ACOs, employers, health plans, and international partners. Through innovative pharmacogenetic testing, precision medicine software, consultative services, and educational resources, Genomind aims to advance mental health care and empower both patients and professionals.

Triple Ring accelerates the pace of innovation allowing our partner companies to drive growth, start new businesses, launch breakthrough products, improve health, and change lives. We are a healthcare-focused Corporate Growth Lab headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. Our services span three key business lines: Technology translation for US government programs, Corporate Growth Labs, and Technology and product development services. Founded in 2005, Triple Ring has an unparalleled track record supporting clients from startups to many of the world’s largest MedTech and Life Sciences companies.

NIRSense is dedicated to developing advanced patient monitoring solutions that are rugged, reliable, and capable of operating in challenging environments. Founded in 2018, the company focuses on providing hospital-quality monitoring devices for both military and civilian applications, utilizing innovative technologies to enhance patient care and safety.

Epicore Biosystems is a digital health company specializing in biowearables for non-invasive monitoring of hydration, metabolic health, and stress through sweat analysis. Their solutions support industrial workers, athletes, and clinical researchers by converting sweat biomarkers and physiological data into actionable insights for real-time health, safety, and performance management. The company combines expertise in data science, material science, and biomedical engineering to create validated, user-centric wearable technologies, and partners with organizations across healthcare, academia, industry, and public health sectors.

Bulls Run Group is a human-machine systems company specializing in human-centered solutions for high-risk work environments. The company focusses on the integration and implementation of cyber and artificial intelligence technologies, serving sectors such as cyberspace operations, aviation, intelligence analysis, military command and control, maintenance, and logistics. With a foundation in military discipline and engineering rigor, the group offers services across software development, technology consulting, cybersecurity, and operational innovation. Their approach combines cognitive engineering, user experience, system architecture, and rigorous security compliance, supporting clients from concept through secure deployment.

Appia Diagnostic provides instant access to expert oral and maxillofacial diagnostics, empowering healthcare professionals to deliver exceptional care without compromise. Their mission is to transform uncertainty into expertise, supporting practices with reliable diagnostic solutions.

Athena GTX is dedicated to advancing wireless, mobile, patient-worn monitoring solutions for both military and civilian markets. The company focuses on connecting patients and providers through state-of-the-art medical and communication technology, developed and produced in Iowa. Athena GTX aims to enhance patient outcomes by integrating innovative wireless technology with reliable devices, supporting first responders and medical professionals in various challenging environments.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

Fluxergy Inc. is a company focused on revolutionizing point-of-care testing with its innovative, multimodal platform. The company aims to bring laboratory capabilities directly to patients, offering rapid, accurate, and cost-effective diagnostic solutions. Fluxergy's technology is designed to streamline testing processes, making it accessible and viable for clinical and community-level applications. Their mission is to enhance biosecurity and improve diagnostic efficiency across various sectors, including clinical diagnostics and veterinary medicine.

The Vanderbilt School of Engineering is a globally recognized academic and research institution dedicated to producing leaders and innovators in engineering. With a commitment to solving grand challenges, the school offers a diverse range of undergraduate and graduate programs across multiple engineering disciplines, fostering a culture of collaboration and excellence.

The Medical College of Wisconsin (MCW) is dedicated to transforming healthcare through innovative education, research, and patient care. With a focus on academic medicine, MCW aims to improve the health of communities by fostering a collaborative learning environment that integrates medical education with groundbreaking research and comprehensive patient care.

Valtamer is a pioneering company specializing in underwater ICT solutions, rooted in Nordic scientific diving and designed for challenging marine environments. Their flagship product, the Alltab, is an underwater tablet that enables divers to collect data, navigate, and communicate effectively underwater. Valtamer aims to become a global leader in providing innovative solutions for underwater professionals.

Headache Sciences Inc. is a clinical artificial intelligence company pioneering the diagnosis and monitoring of headache disorders, with a primary focus on migraine. Leveraging advanced EEG (electroencephalography) technology and machine learning, the company has developed the world's first objective test for migraine, aiming to address the global challenge of underdiagnosis and misdiagnosis. Their mission is to provide practitioners with innovative tools to improve diagnostics, monitoring, and treatment of headache-related neurogenic and neurodegenerative disorders. With a vision of translating brain electrical activity into a comprehensive suite of diagnostic and monitoring services, Headache Sciences Inc. stands at the forefront of Software as a Medical Device (SaMD) innovation, offering hope through discovery.

LifeBoard Medical is a healthcare-focused company, led by experienced trauma surgeons and experts in software and solution development, aimed at creating technological improvements in trauma care, with an emphasis on advancing situational awareness for improved team dynamics, improving patient outcomes and improved QI reviews. The company demonstrates a strong commitment to research objectivity and regulatory compliance, particularly in managing financial conflicts of interest in publicly funded research.

iGenomeDx is a San Antonio-based molecular diagnostics laboratory dedicated to providing fast, accurate, and actionable results for healthcare providers and patients. Founded by scientists with expertise in genetic research, the company leverages cutting-edge technologies such as PCR and LCMS to deliver a comprehensive menu of diagnostic services, including infectious disease detection, pharmacogenomics, genetic risk assessment, and drug monitoring. iGenomeDx's mission is to enhance clinical decision-making, improve patient care, and reduce healthcare costs through reliable and innovative laboratory solutions. The company is recognized for its commitment to quality, diversity, and community engagement, holding multiple certifications and industry awards. iGenomeDx aims to be the most trusted genetic testing and drug monitoring laboratory in San Antonio, with a vision centered on precision diagnostics, scientific integrity, and excellent customer service.

SIMMEC Training Solutions is a woman-owned, service-disabled veteran-owned small business (WOSB/SDVOSB) providing high-fidelity Tactical Combat Casualty Care (TCCC) training using advanced live models. We specialize in delivering immersive, operationally relevant training environments that replicate battlefield trauma conditions under stress, time pressure, and environmental chaos. Our cadre includes former Special Operations medics and trauma clinicians with real-world deployment experience. All courses align with DoD and CoTCCC standards, supporting combat medics, deploying providers, and allied partner forces. Our training incorporates high-fidelity manikins and cadavers where appropriate, but centers on biologically responsive live tissue models to deliver the highest level of realism and decision-making complexity. SIMMEC is committed to ensuring that live tissue training remains the foundational standard for validating emerging trauma technologies and enhancing military medical readiness. As a Non-Traditional Defense Contractor, SIMMEC is uniquely positioned to support MTEC-funded research through: access to validated, biologically responsive training platforms; benchmark data for simulation and wearable validation; performance observation to support AI and Autonomous Casualty Care (AC2) development; and collaboration in hybrid training model innovation (sim-to-live). We are actively seeking partners involved in trauma simulation, AI/ML triage systems, wearable tech, and data-integrated battlefield medical solutions.

Partner Therapeutics, Inc. (PTx) is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for cancer and other serious diseases. With a strong foundation in oncology, PTx also leads research in infectious diseases, immunology, and urgent clinical needs such as COVID-19 and sepsis. The company integrates research, manufacturing, development, and commercialization to rapidly bring therapies to patients worldwide, emphasizing collaboration with medical and scientific communities to improve patient outcomes and quality of life. PTx's mission-driven approach is supported by a leadership team with deep industry experience and a commitment to advancing late-stage therapeutics that address significant unmet medical needs. The company also maintains a robust compliance program in accordance with state and federal regulations.

Devah Therapeutics specializes in repurposing proven pharmaceutical molecules, applying contemporary scientific approaches to address stress-related, metabolic, and neuropsychiatric conditions that lack effective treatments. By utilizing the FDA 505(b)(2) regulatory pathway, the company accelerates drug development, minimizes clinical risk, and explores new indications for molecules with established safety. Their focus is on restoring resilience and quality of life through therapies underpinned by mechanism-based science. The company's lead program is based on a chemistry estate with decades of safe use, targeting multiple indications through targeted modulation of neurobiological and metabolic pathways.

Sciperio Inc. is a pioneering research and development company at the forefront of physical and biological innovation. With a transdisciplinary engineering approach, Sciperio excels in mechanical, chemical, electrical, and biological sciences, pushing the boundaries of traditional scientific fields to develop next-generation technologies. The company is committed to advancing technology for the betterment of humankind, with core capabilities in additively manufactured electronics, mechatronics, machine learning, printed electronics, and biological engineering. Sciperio's mission is to research new concepts and develop technologies that connect people, mobilize businesses, and enhance life through advanced technology.

Imperial College London is a world-leading university focused on science, technology, engineering, medicine, and business. It is dedicated to addressing global challenges through innovative research and education, fostering a diverse and inclusive community of students and staff.

Exactics specializes in the development of rapid, affordable, and accurate at-home diagnostic tests for infectious diseases. The company employs a consumer-oriented design and scalable technology platforms to provide point-of-need diagnostics that aim to increase early disease detection and convenience, with a focus on lowering costs and minimizing development timelines.

Diadem Biotherapeutics is a biotechnology company focused on developing first- and best-in-class therapeutics by engineering extracellular vesicles to modulate immune responses. Their mission is to innovate beyond existing solutions to address unmet medical needs, leveraging expertise in immunology, bioengineering, and drug development. The company’s proprietary DECOSTAR™ platform enables precise costimulatory activation or repression of immune cells, targeting a range of diseases including cancer and autoimmunity.

Vena Vitals develops noninvasive, continuous blood pressure monitoring solutions to enhance patient management and advance cardiovascular care. Their mission is to enable earlier detection and intervention through advanced monitoring technologies, providing accessible and high-fidelity measurements across various healthcare settings.

Mantel Technologies is dedicated to closing capability gaps through innovative product development and expert technical services. The company emphasizes collaboration with customers, partners, and end users to deliver impactful solutions across various industries, including material systems, veterinary technology, energy and power solutions, and technology discovery.

Biobeat is a global leader in wearable remote patient monitoring technology, revolutionizing hypertension diagnosis and management through innovative, non-invasive, cuff-less blood pressure monitoring systems. Their mission is to ensure all hypertension patients are monitored and managed effectively, empowering healthcare providers with accurate, real-time data to optimize patient care. Biobeat leverages proprietary patented PPG sensor technology and advanced data analytics to deliver continuous, medical-grade monitoring solutions that enhance clinical decision-making, improve patient compliance, and enable proactive interventions. With FDA-cleared and CE-certified devices, Biobeat is committed to transforming healthcare delivery, supporting both in-hospital and home-based care, and driving better patient outcomes worldwide.

MedTech Innovator is the world's largest accelerator for medical device, digital health, and diagnostic companies. Their mission is to improve patients' lives by accelerating the growth of companies transforming healthcare worldwide. They offer programs and resources to support innovators in the medtech industry, including webinars, fellowships, and strategic partnerships.

Noctem Health provides practical digital solutions for managing patients with insomnia and other sleep disorders. Their mission is to offer intuitive, user-centered products and services that enhance the capabilities of healthcare providers in managing sleep-related issues, ensuring clinically validated and evidence-based solutions.

MyFitStrip is a precision wellness platform advancing oral and metabolic health by restoring nitric oxide (NO) bioavailability through clinically grounded, microbiome-directed interventions. Built on validated nitrate–nitrite–NO biology, MyFitStrip uses topical oral delivery (chewing gums and lozenges) to enhance nitric oxide production directly within the oral microbiome—supporting beneficial bacteria (e.g., Neisseria, Rothia, Veillonella) while suppressing pathogenic species linked to inflammation, caries, and infection risk. This approach targets a critical physiological pathway, with evidence linking nitric oxide to vascular function, immune defense, and metabolic health, including improvements in endothelial function, blood pressure regulation, antimicrobial activity, and oral pH balance. The platform is complemented by rapid saliva-based test strips that measure nitric oxide status, pH, and uric acid—creating a closed-loop system that drives personalization, compliance, and real-time lifestyle feedback. MyFitStrip’s product suite includes prebiotic chewing gums, slow-release lozenges, and diagnostic strips, all supported by a portfolio of nitric oxide–related patents and a deep body of clinical and scientific research spanning immunology, cardiovascular health, and microbiome science. MyFitStrip is defining a new category at the intersection of oral microbiome modulation and nitric oxide biology, enabling scalable, non-invasive solutions for oral-systemic health optimization.

Houston Methodist Academic Institute integrates advanced clinical research, education, and healthcare innovation with a focus on translating scientific discoveries into improved patient outcomes. The institute offers accredited graduate and postgraduate medical education, supports interdisciplinary research in major areas such as cancer, cardiology, neuroscience, transplant medicine, and regenerative medicine, and provides extensive infrastructure for digital health and medical technology development. Training and fellowship programs span from medical residencies and fellowships to doctoral and research-oriented positions, supported by collaborations with leading academic and industry partners. The institute leverages core technology platforms, simulation centers, and comprehensive educational pathways to foster future leaders in medicine and biomedical research.

Sense Neuro Diagnostics is dedicated to developing non-invasive technology for the rapid detection and monitoring of stroke and traumatic brain injuries (TBI). Their mission is to improve patient outcomes by providing real-time assessments that enhance the efficiency of care in emergency situations.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health. ARIScience is creating value in two ways: Value 1: ARIScience is developing small molecule assets targeting respiratory depression, cutaneous burn and radiation injuries, antivirals for EBOV and DENV, bacteriostatic antibiotic targeting Staph aureus. Value 2: It's novel AI driven quasi quantum chemistry (AI+QQ) small molecule discovery platform for precision protein inhibition and potentiation.

X-trodes is a pioneering company in wearable electrophysiological monitoring, dedicated to liberating data collection from traditional lab settings. Their mission is to enhance healthcare quality, accessibility, and efficiency by enabling real-life, medical-grade monitoring through innovative, flexible skin patches and advanced sensor technology. Rooted in over a decade of research at Prof. Yael Hanein’s Neuro Engineering laboratory, X-trodes empowers healthcare practitioners, patients, and researchers with actionable insights, personalized treatments, and improved outcomes. Their technology is validated by extensive scientific research and is designed for use in diverse environments, making healthcare more inclusive and accessible for all. X-trodes emphasizes collaboration with industry leaders and research centers, user-friendly design for self-application, and the development of robust data analysis algorithms to ensure high-quality, actionable data in real-world settings.

Inertia is an innovation-driven firm delivering end-to-end design, engineering, prototyping, and manufacturing for medical, clean tech, industrial, safety, and advanced hardware industries. Distinguished by their tightly integrated evidence-based approach—including strategy, human factors, regulatory and advanced manufacturing—they execute at every phase: from early startup product validation through SMB innovation acceleration, to full-scale manufacturing for startup and large enterprises. Their unique differentiator lies in the seamless integration of product strategy, development, and manufacturing under one roof—enabling clients to optimize quality, achieve rapid speed-to-market, and realize measurable cost and risk reductions. With robust quality systems, client-centered project management, and a reputation for transparency, Inertia consistently sets new standards for product innovation and commercialization.

UConn Health is a vibrant, integrated academic medical center that is entering an era of unprecedented growth in academics, research, and clinical care. The campus hosts the Schools of Medicine and Dental Medicine with their respective graduate research programs, medical and dental clinics, and the UConn John Dempsey Hospital, rated as one of the World’s Best Hospitals for Infection Prevention and Patient Experience, and one of America’s Best-in-State Hospitals by Newsweek for the past four years. Recent investments in infrastructure, including new construction and renovated laboratory and teaching spaces, demonstrate a commitment to providing our faculty with access to the best possible infrastructure for scientific discovery, supporting Connecticut's and our region's need for innovation in service of our patients, transformative research, and society. We empower faculty, students, and industry partners to advance solutions that benefit Connecticut and the world, driving innovation, discovery, and societal impact through robust partnerships, state-of-the-art facilities, and a collaborative environment.

Yale University, founded in 1701, is dedicated to expanding and sharing knowledge, inspiring innovation, and preserving cultural and scientific information for future generations. It engages with local and global communities to promote cultural understanding and improve the human condition.

Stanford University, founded nearly 150 years ago, is dedicated to educating students for lives of leadership and contribution with integrity. The university emphasizes advancing fundamental knowledge, cultivating creativity, and pioneering research for effective clinical therapies, while also focusing on societal impact and solutions.

Vail Scientific has developed a non-invasive, breathalyzer, rapid sepsis detection technology designed for point-of-care and early intervention, such as Triage, alongside other vital signs and clinical assessments. The technology may be utilized in many diverse settings including hospitals, urgent care, nursing homes and even mobile military field hospitals. Vail's portable proprietary analyzer weighs less than 9 lbs. The company leverages exhaled nitric oxide (Nobel Prize in Medicine winning molecule) measurement for enhanced sensitivity and speed in sepsis screening, aiming to reduce mortality rates and improve patient outcomes. Since 2019, Vail Scientific has focused on clinical research, device innovation, and advancing toward commercialization/regulatory clearance.

The University of Tennessee, Knoxville is dedicated to advancing knowledge and understanding through research, scholarship, and creative work. The Office of Research, Innovation, and Economic Development supports faculty, staff, and students in developing competitive proposals and fostering a strong culture of research integrity, aiming to create a more just, prosperous, and sustainable world.

The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

Pinetics is a leader in product design and development, specializing in delivering agile, manufacturing-ready solutions for clients worldwide. With over 18 years of industry experience, Pinetics offers expertise across the entire product development lifecycle, including electronics hardware, firmware, embedded operating systems, IoT, IoMT, and industrial design. The company serves diverse sectors such as Medtech, Industrial Automation, Defence, and Automotive & EV, helping clients transform bold ideas into impactful realities through end-to-end development, prototyping, and regulatory compliance.

Moberg Analytics is pioneering the future of neuromonitoring with the first and only AI Ecosystem for neurocritical care. The company leverages AI, machine learning, and next-gen analytics to enhance patient care and data management in neurocritical care settings, focusing on traumatic brain injury (TBI) and other neurological conditions.

Halite Medical is building the secure, interoperable AI infrastructure that transforms emergency and battlefield medicine. Our platform ensures that critical patient data flows securely and continuously from the point of injury through every stage of care, enabling predictive, life-saving decisions in the most time-sensitive environments.

Unify Medical is dedicated to improving the quality of care for surgeons and patients through innovative digital visualization solutions. Their mission focuses on enhancing surgical precision and patient outcomes with advanced wearable technology, such as the patented Amplio™ platform, which provides real-time visualization and data capabilities during surgical procedures.

MitoSense, Inc. is a research and development company focused on developing treatments for neurodegenerative diseases through innovative mitochondrial therapies. With exclusive licensing of Mitochondria Organelle Transplantation (MOT™) technology, MitoSense aims to improve the lives of patients suffering from conditions such as ALS, Alzheimer's, and Parkinson's disease.

Innsightful is an AI-driven wearable platform designed to manage fatigue and mental wellness. It provides personalized, real-time interventions to help individuals cope with stress and emotional challenges, utilizing advanced technology to monitor physiological signals and deliver tailored support.

Tensentric is a contract design and manufacturing firm focused solely on medical device, in vitro diagnostic, and advanced therapy markets. We're ISO13485 certified and FDA registered to help our clients bring their new technology and products to market.

SPOC Biosciences is a life sciences technology company focused on advancing proteomics through high-plex biosensor chip platforms. The company enables high-throughput, cost-effective protein production and deep characterization of protein interactions using techniques such as cell-free expression and multiplexed SPR biosensing. Their platform accelerates drug discovery, AI-driven drug design, biomarker identification, diagnostics, antibody screening, and vaccine development by generating scalable, high-resolution kinetic datasets suitable for advanced analytics and AI model training.

Columbia University is a leading Ivy League research university in New York City, founded in 1754. It comprises undergraduate and graduate programs across 17+ schools, a world-renowned medical center, nearly 200 research centers and institutes, and extensive campus-life and student-services resources. Columbia supports broad disciplinary research (examples in the new content: extensive faculty-hosted publications and CVs such as those for Dustin R. Rubenstein), interdisciplinary initiatives (Columbia Climate School, Columbia Global Centers), and public events, conferences and workshops. Faculty labs and departmental pages host teaching and research materials (lecture notes, method papers, and open-access PDFs). Columbia also preserves and documents its technological and computing heritage: the IBM 650 Magnetic Drum Data Processing Machine was the first general-purpose computer installed and used at Columbia (Watson Scientific Computing Laboratory, installed beginning August 1955), and important early software work (e.g., the SOAP assembler) and intensive computing courses were developed and taught on these machines. Recent leadership transitions and active public programming continue alongside ongoing research expansion and global engagement. (Overview synthesized from Columbia University pages, faculty-hosted materials, and the Columbia Computing History archive.)

Scissortail Therapeutics is a biopharmaceutical company focused on developing precision biologics for musculoskeletal injuries and osteoarthritis. The company emphasizes innovative, targeted therapeutics that aim to address the underlying mechanisms of joint disease, collaborating with diverse stakeholders such as academic institutions and clinicians to advance joint protection and regeneration. Scientific rigor, patient-centricity, innovation, and collaboration are central values supporting its mission to create transformative therapies.

The Icahn School of Medicine at Mount Sinai, located in New York City, is an international leader in biomedical education, research, and patient care. As the academic partner of the Mount Sinai Health System, the school is renowned for its innovative education, groundbreaking research, and commitment to health equity. With over 7,000 faculty, 1,200 students, and 2,500 residents and fellows, the institution fosters a culture of bold thinking, multidisciplinary teamwork, and a willingness to challenge conventional wisdom. Its mission is to radically advance the art and science of medical care through collaborative learning, scholarly inquiry, and a deep respect for diversity, preparing the next generation of healthcare leaders to revolutionize medicine and biomedical science.

Zymeron is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative healthcare technologies that deliver step-change performance. The company focuses on proactive health solutions to address critical unmet needs in the pharmaceutical sciences, particularly in drug delivery and formulation technologies.

Cambridge Medical Technologies (CMT) is pioneering a transformative leap in combat casualty and critical care medicine with its advanced biosensor platform. Originally founded on research funded by DARPA, the Army Research Office (ARO), and Walter Reed Army Institute of Research, CMT’s mission has been clear from the start: develop non-invasive, real-time monitoring of blood chemistry for soldiers in the field. Their breakthrough technology samples subcutaneous interstitial fluid (ISF) painlessly and analyzes it outside the body for key biomarkers—starting with glucose and lactate, and now expanding to include blood pH. This innovation is especially critical in military medicine, where early detection of hemorrhagic shock, sepsis, and metabolic failure can mean the difference between life and death. Traditional vital signs like heart rate and blood pressure often fail to reveal the severity of internal injuries or compensated shock. CMT’s biosensor platform fills this gap by continuously tracking biochemical indicators that reflect tissue perfusion (lactate), acid-base status (pH/base deficit), and stress response (glucose). These metrics are widely recognized in both civilian and military clinical guidelines as essential for guiding resuscitation and predicting outcomes. Unlike conventional blood tests that require invasive sampling and lab processing, CMT’s devices—such as the LabPatch and LabClasp—use a proprietary method to extract ISF through the skin without needles. Within seconds, they deliver accurate readings of lactate and glucose, with pH integration underway. This allows medics and clinicians to monitor trends in real time, enabling faster, more informed decisions during trauma care, sepsis management, and evacuation triage. For combat medics operating in austere environments, this technology is a game-changer. A wearable patch could continuously stream vital biochemical data from a wounded soldier to a handheld device, alerting caregivers to rising lactate or falling pH before traditional signs deteriorate. In emergency departments and ICUs, the same platform could reduce reliance on repeated blood draws, improve response times, and enhance patient outcomes. CMT’s work aligns directly with the goals of the Department of Defense’s Advanced Medical Monitor (AMM) initiative under the Medical Technology Enterprise Consortium (MTEC). As future combat operations are expected to produce mass casualties and strain medical resources, integrating biochemical monitoring into standard vital sign systems is no longer optional—it’s urgent. CMT’s technology offers a scalable, field-ready solution that brings ICU-level insight to the point of injury. In summary, CMT is redefining how we monitor and manage shock and sepsis in both military and civilian care. By combining non-invasive ISF sampling with rapid, multi-analyte analysis, their platform empowers caregivers with the data they need—when and where they need it most. COMPANY BACKGROUND: EXECUTIVES: Dr. John Currie, Inventor & Chief Science Officer, Jack Jachmann, CEO, ¤ James Cooke, CFO. FUNDING: $30M in investment. GRANTS: 3 SBIR awards totaling $2M. EXPERIENCE: 8 years of operation. INTELLECTUAL PROPERTY: 14 US and international patents. TEAM: 21 employees. LOCATIONS: Maryland & California (US), United Kingdom, Japan. MANUFACTURING: 2 contract chip manufacturers (US and Japan). CLINICAL TRIALS: 3 hospital sites in Massachusetts, 1 in Minnesota, 1 in Colorado. FOCUS AREAS: Emergency Medicine, Diabetes, Alcoholism & Addiction. MARKET: We are one year away from launching our monitor product, which will initially support four analytes, with additional planned analytic capabilities employing the same platform.

Axiom Management Solutions is a veteran-owned business offering consulting and service support across all stages of medical device development. Axiom's core philosophy: Early-stage medtech innovators deserve to own their development journey without the burden of heavy overhead or restrictive partnerships. Axiom empowers developers to bring their vision to life with precision, flexibility and expert support. The company specializes in helping innovators navigate regulatory requirements, develop prototypes, establish quality management systems, and take medical devices from concept to commercialization.

Scientific and Medical Affairs Consulting, LLC (SMAC) is an integrated drug development and life cycle management support company. SMAC provides nimble, data-driven scientific, medical affairs, and commercial expertise to bridge early development through commercialization for biotechnology and pharmaceutical companies. With a team of seasoned professionals, SMAC delivers tailored strategies and solutions to optimize drug development, regulatory submissions, and commercialization, aiming to accelerate innovative therapies and improve patient outcomes.

Flosonics Medical is dedicated to improving patient care through innovative ultrasound technology. Their flagship product, FloPatch, is the first wireless, wearable Doppler ultrasound device designed to provide real-time hemodynamic assessments, enabling clinicians to make informed decisions regarding fluid resuscitation and management, particularly in critical care settings.

Altrix Medical is dedicated to transforming emergency medical response through innovative technology. Founded in 2013, the company is driven by a mission to prevent and cure disease by leveraging cutting-edge engineering and imaginative ideas. Their flagship product, the SmartAED, aims to make life-saving defibrillation accessible anywhere, anytime, by integrating advanced features into a compact, portable device. Altrix Medical is committed to making emergency care more effective and accessible, ultimately saving more lives.

Signature Science, LLC is a multidisciplinary applied science and technology company dedicated to solving the toughest forensic, biosecurity, and public health challenges. Serving both government and commercial clients, Signature Science combines scientific rigor with proven quality assurance to enhance the credibility and defensibility of programs in national security, public safety, and health security. The company is recognized for its innovation, technical excellence, and commitment to advancing the state-of-the-art in forensic science, genomics, and biosecurity technologies. Signature Science also offers advanced bioinformatics and microbiome analysis services, empowering clients with data-driven insights to address emerging threats, pandemics, and bioterrorism. The company is a subsidiary of Southwest Research Institute and is committed to community engagement and workforce development.

Dasion is a healthcare technology company pioneering the use of advanced machine learning and artificial intelligence to deliver fast, explainable clinical decision support. Their mission is to empower healthcare organizations and professionals to leverage their proprietary Geometric Unified Learning (GUL) technology for improved diagnostics, treatment planning, and patient care. Dasion's solutions focus on enhancing healthcare outcomes and quality of life for all ages by providing real-time, predictive analytics and actionable insights from diverse data sources, including voice and medical imaging.

Veteran-owned Small Business (VOSB) with core capabilities in supply chain technologies and systems design. Patent pending for a nanotechnology-based, autonomous, non-intrusive inspection (NII), multi-target analyte sensor. Founder/CEO doctoral dissertation-based design of an innovative, rural area, agricultural business supply chain system technology cooperative (SmartHub).

Scopemed focuses on innovative respiratory care by developing modular, multifunctional oxygen delivery devices. The company's mission is to leverage clinical innovation to create advanced respiratory solutions capable of high flow oxygen therapy, positive pressure support, and passive oxygen delivery. Scopemed products aim to enhance safety in medical procedures, reduce respiratory particle transmission, and provide adaptable oxygen therapy across various clinical environments.

The Center for Military Medicine Research (CMMR) at the University of Pittsburgh is dedicated to advancing medical research for wounded service members and their families. The center focuses on trauma, emergency, and critical care, leveraging the university's strengths in medical and engineering fields, and collaborating with Carnegie Mellon University's robotics and AI expertise. CMMR aims to enhance trauma care for warfighters and civilians, contributing to the defense innovation economy.

The Texas A&M Engineering Experiment Station (TEES) is a state agency and part of the Texas A&M University System, dedicated to improving lives through engineering research, workforce development, and technology transition. TEES collaborates with industry, academia, and government to provide innovative solutions to global technical challenges.